Processing 00000000.tx.1: Meta-Analysis of the Association of the Cathepsin D Ala224Val Gene Polymorphism with the Risk of Alzheimers Disease: A HuGE Gene-Disease Association Review Christos Ntais1, Anastasia Polycarpou1 and John P. 

Phrase: "Meta-Analysis of the Association of the Cathepsin D Ala224Val Gene Polymorphism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0282458:Meta-Analysis [Intellectual Product]
   753   C0920317:Meta-Analysis [Research Activity]
   751   C0796451:polymorphism analysis [Diagnostic Procedure]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1042496:Meta [Eukaryote]
   736   C1524024:analysis [Functional Concept]

Phrase: "with the Risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of Alzheimers Disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "A HuGE Gene-Disease Association Review Christos Ntais1,"

Phrase: "Anastasia Polycarpou1"

Phrase: "and"

Phrase: "John P."
Processing 00000000.tx.2: A. 

Phrase: "A."
Processing 00000000.tx.3: Ioannidis1,2,3 1 Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece. 

Phrase: "Ioannidis1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3 1 Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "Molecular Epidemiology Unit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]
   734   C0206173:Molecular Epidemiology [Biomedical Occupation or Discipline]

Phrase: "Department of Hygiene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Epidemiology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014507:Epidemiology [Biomedical Occupation or Discipline]
  1000   C0014508:epidemiology [Functional Concept]
  1000   C0699910:epidemiology [Health Care Activity]

Phrase: "University of Ioannina School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Ioannina,"

Phrase: "Greece."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018226:Greece [Geographic Area]
Processing 00000000.tx.4: 2 Biomedical Research Institute, Foundation for Research and Technology-Hellas, Ioannina, Greece. 

Phrase: "2 Biomedical Research Institute,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0005540:Biomedical Research [Research Activity]
   861   C0035172:Research Institute [Organization]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]
   812   C1879848:Biomedical [Biomedical Occupation or Discipline]

Phrase: "Foundation for Research"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   816   C2986512:Research Base [Organization]
   790   C0016617:Foundation [Organization]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1626935:Bases [Quantitative Concept]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "Technology-Hellas,"

Phrase: "Ioannina,"

Phrase: "Greece."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018226:Greece [Geographic Area]
Processing 00000000.tx.5: 3 Institute for Clinical Research and Health Policy Studies, Department of Medicine, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA. 

Phrase: "3 Institute for Clinical Research"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Health Policy Studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0018735:Health Policy [Regulation or Law]

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Tufts-New England Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0027965:New England [Geographic Area]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0014282:England [Geographic Area]
   804   C0205099:Center [Spatial Concept]
   804   C0205314:New [Temporal Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Tufts University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA."
Processing 00000000.tx.6: Received for publication August 5, 2003; 

Phrase: "Received for publication August 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.7: accepted for publication October 10, 2003.  

Phrase: "accepted for publication October 10,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2003."
Processing 00000000.tx.8: ABSTRACT TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  A C-to-T polymorphism in exon 2 of the cathepsin D gene encoding cathepsin D (CTSD) has been implicated as a risk factor for Alzheimers disease. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   831   C0871511:methods testing [Intellectual Product]
   801   C0022885:laboratory testing [Laboratory Procedure]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]
   779   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A C-to-T polymorphism in exon 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "of the cathepsin D gene encoding cathepsin D (CTSD)"

Phrase: "has"

Phrase: "been"

Phrase: "implicated as a risk factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0035648:Risk factor [Quantitative Concept]
   797   C0960756:factor A [Organic Chemical]
   760   C0035647:Risk [Qualitative Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "for Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.9: The authors performed a meta-analysis of 14 studies (16 comparisons) with CTSD genotyping (3,174 Alzheimers disease cases and 3,298 controls). 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a meta-analysis of 14 studies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "(16 comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: ")"

Phrase: "with CTSD genotyping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1285573:Genotyping [Laboratory Procedure]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "(3,174 Alzheimers disease cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "3,298 controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.10: Overall, the random effects odds ratio for the T versus the C allele was 1.17 (95% confidence interval (CI): 0.95, 1.44), with some between-study heterogeneity (p < 0.01). 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "the random effects odds ratio for the T"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028873:Odds Ratio [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "versus"

Phrase: "the C allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "1.17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95% confidence interval (CI)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.95,"

Phrase: "1.44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "with some"

Phrase: "between-study heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.11: There was significant between-study heterogeneity but no evidence of a significant association when the first hypothesis-generating study was excluded from the calculations (odds ratio (OR) = 1.11, 95% CI: 0.91, 1.35; 

Phrase: "There"

Phrase: "was"

Phrase: "significant between-study heterogeneity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "but"

Phrase: "no evidence of a significant association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "when"

Phrase: "the first hypothesis-generating study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "excluded from the calculations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
   737   C1441506:Calculation [Activity]

Phrase: "(odds ratio (OR)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.91,"

Phrase: "1.35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.12: p = 0.29). 

Phrase: "p = 0.29"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.13: The summary odds ratio for T carriers versus T noncarriers was similar in subjects carrying or not carrying an apolipoprotein E 4 allele (APOE*4). 

Phrase: "The summary odds ratio for T carriers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0028873:Odds Ratio [Quantitative Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]
   748   C1552616:summary [Intellectual Product]
   748   C1706244:Summary [Intellectual Product]

Phrase: "versus"

Phrase: "T noncarriers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2986416:Noncarrier [Conceptual Entity]

Phrase: "was"

Phrase: "similar in subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "an apolipoprotein E 4 allele (APOE*4)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.14: The increased susceptibility to Alzheimers disease conferred by APOE*4 carriage tended to be more prominent in the presence of the T allele (random effects OR = 6.07, 95% CI: 4.19, 8.79, and OR = 4.09, 95% CI: 3.15, 5.31, in T carriers and noncarriers, respectively). 

Phrase: "The increased susceptibility to Alzheimers disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "conferred by APOE*4 carriage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002085:Allele [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more prominent in the presence of the T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205402:Prominent [Qualitative Concept]

Phrase: "(random effects OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratio [Quantitative Concept]
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "= 6.07,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "4.19,"

Phrase: "8.79,"

Phrase: "and"

Phrase: "OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 4.09,"

Phrase: "95% CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009667:Confidence Interval [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "3.15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "5.31,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439084:>5 [Quantitative Concept]
   861   C0450355:31 [Intellectual Product]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "in T carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "noncarriers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986416:Noncarrier [Conceptual Entity]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.15: The meta-analysis shows that the CTSD polymorphism is not a major risk factor for Alzheimers disease, although a small effect or an enhancement of the APOE*4 effect cannot be excluded. 

Phrase: "The meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the CTSD polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a major risk factor for Alzheimers disease,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "although"

Phrase: "a small effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "an enhancement of the APOE*4 effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   742   C2349975:Enhancement [Activity]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.16: Alzheimer disease; 

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.17: cathepsin D; 

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.18: CTSD; 

Phrase: "CTSD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.19: epidemiology; 

Phrase: "epidemiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014507:Epidemiology [Biomedical Occupation or Discipline]
  1000   C0014508:epidemiology [Functional Concept]
  1000   C0699910:epidemiology [Health Care Activity]

Phrase: ";"
Processing 00000000.tx.20: genetics; 

Phrase: "genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: ";"
Processing 00000000.tx.21: meta-analysis; 

Phrase: "meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: ";"
Processing 00000000.tx.22: polymorphism (genetics) Abbreviations: Abbreviations: CI, confidence interval; 

Phrase: "polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: ")"

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "CI,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.23: OR, odds ratio.  

Phrase: "OR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "odds ratio."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.24: INTRODUCTION TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  Editors note: This paper is also available on the website of the Human Genome Epidemiology Network (http://www.cdc.gov/genomics/hugenet/default.htm).  

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   831   C0871511:methods testing [Intellectual Product]
   801   C0022885:laboratory testing [Laboratory Procedure]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]
   779   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Editors note"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1707884:Editor_Note [Intellectual Product]
   861   C1316572:Note [Clinical Attribute]
   861   C1317574:Note [Intellectual Product]
   861   C1369612:Note [Clinical Attribute]

Phrase: ":"

Phrase: "This paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "is"

Phrase: "also available on the website of the Human Genome Epidemiology Network"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0470187:Available [Functional Concept]
           Availability of

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.cdc.gov/genomics/hugenet/default.htm"

Phrase: ")."
Processing 00000000.tx.25: GENE TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  Cathepsin D, an intracellular acid protease which exhibits beta-secretase activity in vitro, has been implicated in the processing of the amyloid precursor protein and the tau protein (1, 2). 

Phrase: "GENE TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   831   C0871511:methods testing [Intellectual Product]
   801   C0022885:laboratory testing [Laboratory Procedure]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]
   779   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cathepsin D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "an intracellular acid protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]

Phrase: "which"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "beta-secretase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1412727:SECRETASE, BETA [Gene or Genome]
   734   C1454853:beta-Secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the processing of the amyloid precursor protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033666:protein processing [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   742   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "the tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.26: The cathepsin D gene (CTSD) is located on the short arm of chromosome 11 (11p15.5) and consists of nine exons. 

Phrase: "The cathepsin D gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "(CTSD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "is"

Phrase: "located on the short arm of chromosome 11"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0457309:Short arm of chromosome [Cell Component]
   819   C1520354:Chromosome 11 Short Arm [Nucleotide Sequence]
   800   C0449721:Arm of chromosome [Nucleotide Sequence]
           Chromosome Arm
   770   C0008653:Chromosome 11 [Cell Component]
   770   C0426857:Short arm [Finding]
   744   C0008633:Chromosome [Cell Component]
   744   C0446516:Arm [Body Location or Region]
   744   C1269078:Arm [Body Part, Organ, or Organ Component]
   744   C1269612:Arm [Body Location or Region]
   744   C1282927:short [Qualitative Concept]
   744   C1806781:Short [Quantitative Concept]
   744   C2350002:Short [Quantitative Concept]

Phrase: "(11p15.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1520373:11p15.5 [Cell Component]
   861   C1520364:11p15 [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "consists of nine exons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0205455:Nine [Quantitative Concept]
   770   C0332529:CONSIST [Qualitative Concept]
Processing 00000000.tx.27: The synthesis of beta-amyloid peptide is a putative key event in the pathogenesis of Alzheimers disease. 

Phrase: "The synthesis of beta-amyloid peptide"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C1327133:peptide synthesis [Molecular Function]
   783   C1518961:Peptide Synthesis [Research Activity]
   783   C2945683:Peptide synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "a putative key event in the pathogenesis of Alzheimers disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0441471:Event [Event]
Processing 00000000.tx.28: Beta-amyloid derives from its precursor protein via proteolytic cleavage by secretases. 

Phrase: "Beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2825879:Amyloid, Beta [Laboratory Procedure]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "derives from its precursor protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "via proteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "by secretases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.29: Therefore, it has been postulated that variants in the genes coding for enzymes involved in the proteolytic cleavage of amyloid precursor protein or in the degradation and clearance of beta-amyloid from the central nervous system may be potential risk factors for Alzheimers disease.  

Phrase: "Therefore,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "that variants in the genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]

Phrase: "coding for enzymes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0009219:Coding [Occupational Activity]
   790   C0014442:Enzymes [Enzyme,Organic Chemical]
   790   C0014445:enzymes [Functional Concept]
   756 E C0805701:Code [Intellectual Product]

Phrase: "involved in the proteolytic cleavage of amyloid precursor protein"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0597304:Protein Cleavage [Molecular Function]
           Proteolytic
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0010813:cleavage [Cell Function]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1314939:Involved [Functional Concept]
   742   C1330957:cleavage [Cell Function]
   742   C1709634:Precursor [Idea or Concept]
   742   C1947941:proteolytic [Enzyme]

Phrase: "or in the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "clearance of beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C3269198:beta-amyloid clearance [Biologic Function]
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "be"

Phrase: "potential risk factors for Alzheimers disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0850664:disease factors risk [Finding]
   790   C0035648:risk factors [Quantitative Concept]
   790   C1553898:risk factors [Idea or Concept]
   783   C0679238:disease factors [Functional Concept]
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.30: GENE VARIANTS TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  The CTSD gene contains a polymorphic C-to-T transition site at position 224 in exon 2. 

Phrase: "GENE VARIANTS TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   828   C0871511:methods testing [Intellectual Product]
   800   C0022885:laboratory testing [Laboratory Procedure]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]
   778   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The CTSD gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a polymorphic C-to-T transition site at position 224"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205145:Site [Spatial Concept]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "in exon 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.31: This polymorphism results in an Ala38-to-Val substitution in the cathepsin D profragment (3). 

Phrase: "This polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "results in an Ala38-to-Val substitution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1555721:Substitution [Idea or Concept]
   748   C1706204:Substitution [Activity]
   748   C2825142:Result [Finding]

Phrase: "in the cathepsin D profragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.32: The polymorphism has been associated with increased secretion and altered intracellular maturation of the cathep-sin D profragment in one study (3). 

Phrase: "The polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "associated with increased secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "altered intracellular maturation of the cathep-sin D profragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0678723:Maturation [Organism Function]
   742   C0870861:maturation [Phenomenon or Process]
   742   C1254042:Maturation [Physiologic Function]

Phrase: "in one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.33: Moreover, the T allele has been associated with a 50 percent decrease in beta-amyloid peptide 142 levels in the cerebrospinal fluid of patients with Alzheimers disease (4). 

Phrase: "Moreover,"

Phrase: "the T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "associated with a 50 percent decrease"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0392756:Decrease [Qualitative Concept]
   753   C0439165:Percent [Quantitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in beta-amyloid peptide 142 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.34: Finally, this polymorphism was recently reported to be significantly associated with general intelligence in healthy elderly people (5). 

Phrase: "Finally,"

Phrase: "this polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significantly"

Phrase: "associated with general intelligence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0021704:Intelligence [Mental Process]
   770   C0205246:General [Spatial Concept]
   770   C1553889:General [Idea or Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in healthy elderly people"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027361:People [Population Group]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.35: Molecular epidemiologic studies have presented seemingly contradictory results concerning a potential role of CTSD polymorphism in Alzheimers disease (619). 

Phrase: "Molecular epidemiologic studies"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0002783:Epidemiologic Studies [Research Activity]
   865   C0206173:Molecular Epidemiologies [Biomedical Occupation or Discipline]
   827   C0014507:Epidemiologic [Biomedical Occupation or Discipline]
   827   C0014508:epidemiologic [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C0699910:epidemiology [Health Care Activity]

Phrase: "have"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "seemingly contradictory results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "a potential role of CTSD polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(619"

Phrase: ")."
Processing 00000000.tx.36: There is also controversy on whether this polymorphism may interact with the apolipoprotein E 4 allele (APOE*4), which is the best known genetic determinant for sporadic Alzhei-mers disease (20). 

Phrase: "There"

Phrase: "is"

Phrase: "also controversy on"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680243:controversy [Social Behavior]

Phrase: "whether"

Phrase: "this polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "interact with the apolipoprotein E 4 allele"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   814   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   778   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002085:Allele [Gene or Genome]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "the best known genetic determinant for sporadic Alzhei-mers disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1521761:Determinant [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.37: Single studies may have been underpowered to detect interactions or even overall effects. 

Phrase: "Single studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "underpowered to"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "even overall effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.38: Given the amount of accumulated data, we deemed it important to perform a quantitative synthesis of the evidence using rigorous methods. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the amount of accumulated data,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "we"

Phrase: "deemed"

Phrase: "it important to"

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "a quantitative synthesis of the evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rigorous methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.39: Thus, we conducted a comprehensive meta-analysis of all available studies relating the CTSD polymorphism to the risk of Alzheimers disease.  

Phrase: "Thus,"

Phrase: "we"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "a comprehensive meta-analysis of all available studies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1042496:Meta [Eukaryote]
   744   C1524024:analysis [Functional Concept]

Phrase: "relating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0163712:Relate [Organic Chemical]

Phrase: "the CTSD polymorphism to the risk of Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0032529:Polymorphism [Genetic Function]
   739   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.40: DISEASE TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  Alzheimers disease is the most common cause of progressive cognitive impairment in the elderly, with an annual incidence of approximately 1 percent at 6569 years increasing up to 40 percent in the very elderly (>85 years of age) (21, 22). 

Phrase: "DISEASE TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   831   C0871511:methods testing [Intellectual Product]
   801   C0022885:laboratory testing [Laboratory Procedure]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]
   779   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "the most common cause of progressive cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015127:cause [Functional Concept]
   744   C1524003:Cause [Conceptual Entity]

Phrase: "in the elderly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]

Phrase: "with an annual incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0021149:Incidence [Quantitative Concept]
   861   C0220856:incidence [Functional Concept]
   789 E C1551358:incident [Idea or Concept]

Phrase: "of approximately 1 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "at 6569 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "increasing up to 40 percent"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0439165:Percent [Quantitative Concept]
   760   C0439509:/40 [Temporal Concept]
   760   C0442808:Increasing [Functional Concept]
   726 E C0442805:Increase [Functional Concept]

Phrase: "in the very elderly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001792:Elderly [Population Group]
   861   C1999167:elderly [Population Group]

Phrase: "("

Phrase: ">85 years of age) (21,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1510829:Age-Years [Temporal Concept]
   760   C0439234:years [Temporal Concept]
   726 E C0439508:/year [Temporal Concept]

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.41: Mutations in the amyloid precursor protein, presenilin 1, and presenilin 2 genes account for 5 percent of the cases and result in an autosomally dominant pattern that is expressed with complete penetrance and early manifestations (23). 

Phrase: "Mutations in the amyloid precursor protein,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "presenilin 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "presenilin 2 genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Genes [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "account for 5 percent of the cases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0439165:Percent [Quantitative Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   748   C1551359:account [Idea or Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "result in an autosomally dominant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "expressed with complete penetrance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1840470:Complete penetrance [Finding]
   770   C0205197:Complete [Qualitative Concept]
   770   C0524899:Penetrance [Quantitative Concept]
   770   C0725685:COMPLEAT [Food]

Phrase: "and"

Phrase: "early manifestations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205319:manifestations [Functional Concept]
   861   C1280464:manifestations [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.42: Alzheimers disease is probably slightly more common in females (24). 

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "probably slightly more common in females"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.43: Other proven or postulated risk factors include head injury (in particular among males) (25), as well as family history, low income, low education, low occupational status, depression, exposure to aluminum in drinking water, hypertension, and Downs syndrome (26, 27). 

Phrase: "Other proven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456369:Proven [Qualitative Concept]

Phrase: "or"

Phrase: "postulated risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   827   C0035647:Risk [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "head injury"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0018674:Head injury [Injury or Poisoning]
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: "("

Phrase: "in particular"

Phrase: "among males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: ")"

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "family history,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "low income,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032854:Low Income [Group Attribute]
  1000   C0302604:Low income [Finding]
  1000   C1331016:Low income [Finding]
   861   C0021162:Income [Quantitative Concept]

Phrase: "low education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0013621:Education [Educational Activity]
   861   C0013622:education [Classification]
   861   C0013658:Education, NOS [Finding]
   861   C0039401:Education [Educational Activity]
   789 E C1555905:Educational [Intellectual Product]

Phrase: "low occupational status,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0014006:Status, Occupational [Qualitative Concept]
   827   C0449438:Status [Qualitative Concept]

Phrase: "depression,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "exposure to aluminum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "in drinking water,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0599638:Drinking Water [Substance]
           WATER
   861   C0001948:drinking [Individual Behavior]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0684271:Drinking [Organism Function]
   861   C1550678:Water [Inorganic Chemical]
   827 E C0452428:Drink [Food]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "Downs syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   789   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   789   C2626739:Lanugo [Eukaryote]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.44: Conversely, the use of nonsteroidal antiinflammatory drugs to treat arthritis has been associated with a reduced risk of Alzhei-mers disease, as has been estrogen use by postmenopausal women (27). 

Phrase: "Conversely,"

Phrase: "the use of nonsteroidal antiinflammatory drugs to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1524063:Use of [Functional Concept]
   757   C0242510:drug use [Mental or Behavioral Dysfunction]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "arthritis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003864:Arthritis [Disease or Syndrome]
   907 E C0018099:Gout [Disease or Syndrome]

Phrase: "has"

Phrase: "been"

Phrase: "associated with a reduced risk of Alzhei-mers disease,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0243083:associated disease [Pathologic Function]
   762   C1281905:disease risk [Finding]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0035647:Risk [Qualitative Concept]
   742   C0392756:Reduced [Qualitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "estrogen use by postmenopausal women"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0239301:ESTROGEN USE [Finding]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.45: Physical activity, diets with high levels of vitamins B6, B12, and folate, and red wine in moderate quantities may be protective (27). 

Phrase: "Physical activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0026606:Physical activity [Daily or Recreational Activity]
   861   C0031809:Physical [Health Care Activity]
   861   C0205177:Activity [Functional Concept]
   861   C0205485:Physical [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1509143:Physical [Finding]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "diets with high levels of vitamins B6,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0012155:Diets [Food]
   714 E C1442959:Diet [Organism Function]
   714 E C1519433:DIET [Therapeutic or Preventive Procedure]
   714 E C2983588:DIET [Food]

Phrase: "B12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1417635:B12 [Gene or Genome]
  1000   C1420797:B12 [Gene or Genome]
  1000   C3538796:B12 [Gene or Genome]

Phrase: "and"

Phrase: "folate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178638:Folate [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "red wine in moderate quantities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0349371:Red wine [Food]
   760   C0043188:Wine [Food]
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "protective"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.46: The prevalence of Alzheimers disease varies considerably among different population groups (28). 

Phrase: "The prevalence of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033105:Prevalence [Quantitative Concept]
   760   C0220900:prevalence [Quantitative Concept]

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "considerably among different population groups"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C1257890:Population Group [Population Group]
           Group
           Population
   760   C0032659:Population [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.47: At least a few dozens of polymorphisms have been examined in relation to sporadic Alzheimers disease, and published reviews are available (23, 29). 

Phrase: "At least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "a few dozens of polymorphisms"

Phrase: "have"

Phrase: "been"

Phrase: "examined in relation to sporadic Alzheimers disease,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimers disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0080103:Relation [Family Group]
   748   C0205422:Sporadic [Temporal Concept]
   748   C0332128:Examined [Finding]
   748   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "published reviews"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0282443:reviews [Intellectual Product]
   827 E C1552617:Review [Idea or Concept]

Phrase: "are"

Phrase: "available"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.48: Among them, there is conclusive evidence from several studies and meta-analysis thereof that APOE*4 is a strong risk factor for developing Alzheimers disease for both male and female subjects and for both early onset (<65 years) and late-onset disease (20), with an approximately fivefold increase in the odds of developing Alzheimers disease. 

Phrase: "Among them,"

Phrase: "there"

Phrase: "is"

Phrase: "conclusive evidence from several studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "meta-analysis thereof"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "that APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "a strong risk factor for developing Alzheimers disease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0850664:disease risk factor [Finding]
   770   C0035648:Risk factor [Quantitative Concept]
   767   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   767   C0679238:disease factor [Functional Concept]
   767   C0960756:factor A [Organic Chemical]
   767   C1281905:disease risk [Finding]
   744   C0035647:Risk [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "for both male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "female subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and for both early onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1833334:Early-onset [Finding]
   760   C0332162:Onset [Qualitative Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "("

Phrase: "<65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "late-onset disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "with an approximately fivefold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in the odds"

Phrase: "of developing Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.49: Single studies have also implicated other polymorphisms as being important, although the reported odds ratios are much smaller than those seen for APOE*4, and attempts at replication in subsequent research have not been conclusive. 

Phrase: "Single studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "implicated"

Phrase: "other polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "as"

Phrase: "being"

Phrase: "important,"

Phrase: "although"

Phrase: "the reported odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratios [Quantitative Concept]
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "much smaller than those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0547044:Smaller [Qualitative Concept]
   770   C0700321:Smaller [Quantitative Concept]

Phrase: "seen for APOE*4,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   882   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   833   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002085:Allele [Gene or Genome]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205397:Seen [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "attempts at replication"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0598312:Replication [Genetic Function]
   790   C1516084:Attempt [Event]
   790   C1883725:replication [Qualitative Concept]
   718 E C0205173:Replicate [Functional Concept]
   718 E C0205341:Replicate [Functional Concept]

Phrase: "in subsequent research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "conclusive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828146:Conclusive [Qualitative Concept]
Processing 00000000.tx.50: Meta-analyses for some other polymorphisms have already appeared in the literature (3035). 

Phrase: "Meta-analyses for some"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0920317:meta-analyses [Research Activity]
   799 E C0282458:Meta-Analysis [Intellectual Product]
   770   C1042496:Meta [Eukaryote]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "other polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "already"

Phrase: "appeared in the literature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023866:Literature [Intellectual Product]
   770   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   737   C0700364:APPEAR [Qualitative Concept]

Phrase: "(3035"

Phrase: ")."
Processing 00000000.tx.51: They suggest no significant overall associations for several of these polymorphisms, including the myeloperoxidase gene promoter polymorphism (30), intronic or promoter region polymorphisms of presenilin 1 (for late-onset disease) (31), an insertion-deletion polymorphism or a missense mutation in the alpha-2 macroglobulin gene (32), and several polymorphisms of the protein tau gene (33). 

Phrase: "They"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "no significant overall associations for several of these polymorphisms,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0004083:Associations [Mental Process]
   708 E C0439849:Association [Qualitative Concept]
   708 E C0596306:Association [Phenomenon or Process]
   708 E C0699792:association [Social Behavior]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the myeloperoxidase gene promoter polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0678951:gene polymorphism [Genetic Function]
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "intronic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "promoter region polymorphisms of presenilin 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "("

Phrase: "for late-onset disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "an insertion-deletion polymorphism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0021107:Insertion [Therapeutic or Preventive Procedure]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0441587:Insertion [Health Care Activity]
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1512796:Insertion [Genetic Function]
   827   C1880274:Deletion [Activity]
   827   C1882417:Polymorphism [Qualitative Concept]
   827   C1883719:Insertion [Functional Concept]

Phrase: "or"

Phrase: "a missense mutation in the alpha-2 macroglobulin gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0599155:Missense Mutation [Genetic Function]
   762   C0596611:Gene Mutation [Genetic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "several polymorphisms of the protein tau gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0678951:gene polymorphisms [Genetic Function]
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.52: Associations of modest effect size (odds ratios (ORs) = 1.301.35) have been claimed in meta-analyses of the low density lipoprotein receptor-related protein gene exon 3 polymorphism (34) and of an insertion-deletion polymorphism in the angiotensin-converting enzyme I gene (35).  

Phrase: "Associations of modest effect size"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0004083:Associations [Mental Process]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "(odds ratios (ORs)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "= 1.301.35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "claimed in meta-analyses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0920317:meta-analyses [Research Activity]
   799 E C0282458:Meta-Analysis [Intellectual Product]
   770   C1042496:Meta [Eukaryote]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "of the low density lipoprotein receptor-related protein gene exon 3 polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   824   C0678951:gene polymorphism [Genetic Function]
   790   C0032529:Polymorphism [Genetic Function]
   790   C1882417:Polymorphism [Qualitative Concept]
   752   C1416915:LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 3 [Gene or Genome]
   707   C1366529:Low density lipoprotein receptor gene [Gene or Genome]

Phrase: "(34"

Phrase: ")"

Phrase: "and of an insertion-deletion polymorphism"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0021107:Insertion [Therapeutic or Preventive Procedure]
   753   C0032529:Polymorphism [Genetic Function]
   753   C0441587:Insertion [Health Care Activity]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1512796:Insertion [Genetic Function]
   753   C1515981:And [Idea or Concept]
   753   C1880274:Deletion [Activity]
   753   C1882417:Polymorphism [Qualitative Concept]
   753   C1883719:Insertion [Functional Concept]

Phrase: "in the angiotensin-converting enzyme I gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1333402:Enzyme Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C0022709:angiotensin converting enzyme i [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
           Angiotensin Converting Enzyme
   708   C0003006:Angiotensin I [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.53: META-ANALYSIS METHODS TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  Identification and eligibility of relevant studies We considered all studies that examined the association of the CTSD polymorphism with Alzheimers disease. 

Phrase: "META-ANALYSIS METHODS TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   878   C0871511:methods testing [Intellectual Product]
           methods tests
   799   C0022885:laboratory testing [Laboratory Procedure]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]
   777   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "eligibility of relevant studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013893:Eligibility [Health Care Activity]

Phrase: "We"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "all"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the association of the CTSD polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.54: Sources included MEDLINE and EMBASE (from January 1994 to September 2003). 

Phrase: "Sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449416:sources [Finding]
   966 E C1705919:Source [Idea or Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MEDLINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "and"

Phrase: "EMBASE"

Phrase: "("

Phrase: "from January 1994"

Phrase: "to September 2003"

Phrase: ")."
Processing 00000000.tx.55: The search strategy was based on combinations of "Alzheimers disease," "CTSD," "cathepsin D," "polymorphism," "allele," and "genetics." 

Phrase: "The search strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "based on combinations of ""Alzheimers disease,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0453882:Combinations [Manufactured Object]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C0205195:Combination [Qualitative Concept]
   719 E C1880279:Base [Biomedical or Dental Material]
   719 E C1947911:Combination [Physical Object]

Phrase: """ ""CTSD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: """ ""cathepsin D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: """ ""polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: """ ""allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: """"

Phrase: "and """

Phrase: "genetics."""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]
Processing 00000000.tx.56: References of retrieved articles were also screened. 

Phrase: "References of retrieved articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1514811:Reference [Idea or Concept]
   737   C1706462:Reference [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "screened."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]
Processing 00000000.tx.57: Case-control studies were eligible if they had determined the distribution of CTSD genotypes in Alzheimers disease cases (regardless of age of onset) and in a concurrent control group of dementia-free subjects using a molecular method for genotyping. 

Phrase: "Case-control studies"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C0007328:Case-Control Studies [Research Activity]
   913   C0085973:Case Studies [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0868928:Case [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "eligible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548635:eligible [Idea or Concept]

Phrase: "if"

Phrase: "they"

Phrase: "had"

Phrase: "determined"

Phrase: "the distribution of CTSD genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in Alzheimers disease cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "("

Phrase: "regardless of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: ")"

Phrase: "and in a concurrent control group of dementia-free subjects"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   760   C0009932:Control Group [Group]
   757   C0441835:Group A [Classification]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0205420:Concurrent [Temporal Concept]
   739   C0243148:control [Qualitative Concept]
   739   C0332296:free [Functional Concept]
   739   C0441833:Group [Idea or Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0687744:group [Population Group]
   739   C1257890:Group [Population Group]
   739   C1515981:And [Idea or Concept]
   739   C1550141:Control [Substance]
   739   C1552516:Group [Health Care Related Organization]
   739   C1705428:Group [Conceptual Entity]
   739   C1705429:Group [Population Group]
   739   C1880497:Free [Qualitative Concept]
   739   C1882979:Control [Conceptual Entity]
   739   C1996904:Free [Qualitative Concept]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]
   706   C0681850:Subject [Group]
   706   C1550501:{Subject} [Idea or Concept]
   706   C1706203:Subject [Idea or Concept]
   706   C2349001:Subject [Human]
   706   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a molecular method for genotyping."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.58: Cases with Alzheimers disease were eligible regardless of whether they had a family history of Alzhei-mers disease or not. 

Phrase: "Cases with Alzheimers disease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "eligible regardless of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1548635:eligible [Idea or Concept]

Phrase: "whether"

Phrase: "they"

Phrase: "had"

Phrase: "a family history of Alzhei-mers disease"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   840   C0850707:family history of disease [Finding]
           disease family history
   778   C0241889:Family history [Finding]
   778   C1705495:Family History [Idea or Concept]
   777   C0683519:History of diseases [Finding]
           disease history
   774   C0344339:disease family [Finding]
   748   C0015576:Family [Family Group]
   748   C0019664:History [Occupation or Discipline]
   748   C0019665:history [Intellectual Product]
   748   C0262512:History, NOS [Organism Attribute]
   748   C0262926:History [Finding]
   748   C1704727:Family [Conceptual Entity]
   748   C1705255:History [Conceptual Entity]
   748   C2004062:History [Finding]
   738 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "or"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.59: However, we excluded family-based studies of pedigrees with several affected cases per family, because their analysis is based on linkage considerations. 

Phrase: "However,"

Phrase: "we"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "family-based studies of pedigrees"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0199236:family studies [Diagnostic Procedure]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "with several affected cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "per family,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "because"

Phrase: "their analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "based on linkage considerations."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0023745:linkage [Molecular Function]
   770   C0518609:considerations [Finding]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.60: Data extraction Two investigators independently extracted data and reached consensus on all items. 

Phrase: "Data extraction Two investigators independently extracted data"

Phrase: "and"

Phrase: "reached consensus on all items."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0376298:Consensus [Social Behavior]
Processing 00000000.tx.61: The following information was sought from each report: authors, journal and year of publication, country of origin, selection and characteristics of Alzheimers disease cases and controls, demographics, ethnic group of the study population, eligible and genotyped cases and controls, and number of cases and controls for each CTSD genotype. 

Phrase: "The following information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "was"

Phrase: "sought from each report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]

Phrase: ":"

Phrase: "authors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "journal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "year of publication,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439234:year [Temporal Concept]
   790   C0439508:/year [Temporal Concept]

Phrase: "country of origin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1300001:Country of origin [Finding]
           Origin - country
  1000   C1549631:Country Of Origin [Idea or Concept]
  1000   C3262211:Country of origin [Clinical Attribute]
   790   C0454664:Country [Geographic Area]

Phrase: "selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]

Phrase: "and"

Phrase: "characteristics of Alzheimers disease cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0599878:characteristics disease [Pathologic Function]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "demographics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011292:Demographics [Idea or Concept]
  1000   C0011298:Demographics [Occupation or Discipline]
  1000   C1704791:Demographics [Idea or Concept]

Phrase: "ethnic group of the study population,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   820   C2348561:Study Population (group) [Population Group]
   790   C0015031:Ethnic group [Population Group]
           Ethnic population, NOS
           ETHNIC
   790   C1879937:Ethnic Group [Intellectual Product]
   783   C1257890:Population Group [Population Group]
           Group
   753   C0441833:Group [Idea or Concept]
   753   C0680174:ethnic [Finding]
   753   C0687744:group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "eligible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548635:eligible [Idea or Concept]

Phrase: "and"

Phrase: "genotyped cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "number of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "controls for each CTSD genotype."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1332805:CATHEPSIN D [Gene or Genome]
   753   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017431:Genotype [Organism Attribute]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.62: For studies including subjects of different ethnic groups, data were extracted separately for each ethnicity, whenever possible. 

Phrase: "For studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "subjects of different ethnic groups,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "separately for each ethnicity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015031:Ethnicity [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]

Phrase: "whenever"

Phrase: "possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.63: Furthermore, we examined whether matching had been used, whether there was specific mention of blinding of the personnel who performed the genotyping to the clinical status of the subjects, and whether the genotyping method had been validated. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "matching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:MATCHING [Research Activity]
  1000   C1708943:Matching [Qualitative Concept]

Phrase: "had"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "whether"

Phrase: "there"

Phrase: "was"

Phrase: "specific mention of blinding of the personnel"

Phrase: "who"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the genotyping to the clinical status of the subjects,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1285573:Genotyping [Laboratory Procedure]

Phrase: "and"

Phrase: "whether"

Phrase: "the genotyping method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "had"

Phrase: "been"

Phrase: "validated."
Processing 00000000.tx.64: Meta-analysis The primary analysis compared Alzheimers disease cases with controls for the contrast of T versus C alleles. 

Phrase: "Meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "The primary analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "Alzheimers disease cases with controls"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   764   C0872128:case control [Health Care Activity]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "for the contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "of T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "versus"

Phrase: "C alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.65: This analysis aims to detect overall differences. 

Phrase: "This analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "aims"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]
  1000   C3540473:AIMS [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "overall differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.66: We also examined the contrast of extremes (homozygotes), T/T versus C/C. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the contrast of extremes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1979874:Contrast [Qualitative Concept]

Phrase: "(homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygotes [Organism Attribute]

Phrase: ")"

Phrase: ","

Phrase: "T/T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "versus"

Phrase: "C/C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.67: Finally, we examined the contrast of T/T versus (C/T + C/C) and the contrast of (C/T + T/T) versus C/C. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the contrast of T/T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1979874:Contrast [Qualitative Concept]

Phrase: "versus"

Phrase: "(C/T +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "C/C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the contrast of (C/T + T/T)"

Phrase: "versus"

Phrase: "C/C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.68: These contrasts correspond to the recessive and dominant effects, respectively, of the T allele. 

Phrase: "These contrasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1979874:Contrast [Qualitative Concept]

Phrase: "correspond to the recessive"

Phrase: "and"

Phrase: "dominant effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "respectively,"

Phrase: "of the T allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.69: The odds ratio was used as the metric of choice. 

Phrase: "The odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "used as the metric of choice."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1524063:Use of [Functional Concept]
   753   C0008300:choice [Individual Behavior]
   753   C0699680:Metric [Organic Chemical,Pharmacologic Substance]
   753   C1273517:used [Finding]
   753   C1707391:Choice [Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.70: For each genetic contrast, we estimated the between-study heterogeneity across all eligible comparisons using the chi-square-based Q statistic (36). 

Phrase: "For each genetic contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "the between-study heterogeneity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0019409:Heterogeneity [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "across all eligible comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the chi-square-based Q statistic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C2348149:Statistic [Quantitative Concept]
   804   C2828391:Statistic [Quantitative Concept]
   733 E C0038215:Statistical [Occupation or Discipline]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.71: Heterogeneity was considered significant for p < 0.10. 

Phrase: "Heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significant for p < 0.10."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.72: Data were combined using both fixed-effects (Mantel-Haenszel) and random-effects (DerSimonian and Laird) models (37). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both"

Phrase: "fixed-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "(Mantel-Haenszel"

Phrase: ")"

Phrase: "and"

Phrase: "random-effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0034656:RANDOM [Research Activity]
   861   C0439605:Random [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "(DerSimonian"

Phrase: "and"

Phrase: "Laird"

Phrase: ")"

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.73: Random effects incorporate an estimate of the between-study variance and tend to provide wider confidence intervals, when the results of the constituent studies differ among themselves. 

Phrase: "Random effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0034656:RANDOM [Research Activity]
   861   C0439605:Random [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "incorporate"

Phrase: "an estimate of the between-study variance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750572:Estimate [Quantitative Concept]

Phrase: "and"

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "wider confidence intervals,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "when"

Phrase: "the results of the constituent studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results studies [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "differ among themselves."
Processing 00000000.tx.74: In the absence of between-study heterogeneity, the two methods provide identical results. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of"

Phrase: "between-study heterogeneity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "the two methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "identical results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.75: Random effects are more appropriate when heterogeneity is present (37). 

Phrase: "Random effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0034656:RANDOM [Research Activity]
   861   C0439605:Random [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "more appropriate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1548787:Appropriate [Qualitative Concept]
   789 E C0814634:appropriateness [Qualitative Concept]

Phrase: "when"

Phrase: "heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.76: We also performed cumulative meta-analysis (38) and recursive cumulative meta-analysis (39, 40) to evaluate whether the summary odds ratio for the T versus C contrast changed over time as more data accumulated and whether the strength of the association changed when the first hypothesis-generating study was excluded from the calculations (41). 

Phrase: "We also"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "cumulative meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "(38"

Phrase: ")"

Phrase: "and"

Phrase: "recursive cumulative meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0282458:Meta-Analysis [Intellectual Product]
   861   C0920317:Meta-Analysis [Research Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1042496:Meta [Eukaryote]
   812   C1524024:analysis [Functional Concept]

Phrase: "(39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "whether"

Phrase: "the summary odds ratio for the T"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0028873:Odds Ratio [Quantitative Concept]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]
   748   C1552616:summary [Intellectual Product]
   748   C1706244:Summary [Intellectual Product]

Phrase: "versus"

Phrase: "C contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "changed over time"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0392747:Changed [Functional Concept]
   790   C0443172:Changed [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C1705241:Change [Quantitative Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "as"

Phrase: "more data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "accumulated"

Phrase: "and"

Phrase: "whether"

Phrase: "the strength of the association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237897:Strength [Quantitative Concept]
   760   C0808080:Strength [Idea or Concept]
   760   C1705922:Strength [Qualitative Concept]

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "when"

Phrase: "the first hypothesis-generating study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "excluded from the calculations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
   737   C1441506:Calculation [Activity]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.77: Inverted funnel plots and the Begg-Mazumdar publication bias diagnostic (nonparametric correlation coefficient) (42) evaluated whether the magnitude of the observed association was related to the variance of each study, that is, whether large studies gave different results compared with smaller ones (43). 

Phrase: "Inverted funnel plots"

Phrase: "and"

Phrase: "the Begg-Mazumdar publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034036:Publication [Intellectual Product,Manufactured Object]
   827   C0034037:Publication [Occupational Activity]
   827   C1704324:Publication [Intellectual Product]

Phrase: "bias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]

Phrase: "diagnostic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011900:Diagnostic [Finding]
  1000   C0348026:Diagnostic [Functional Concept]

Phrase: "(nonparametric correlation coefficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1707429:*Coefficient [Quantitative Concept]
   827   C1707520:Correlation [Qualitative Concept]

Phrase: ")"

Phrase: "(42"

Phrase: ")"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "whether"

Phrase: "the magnitude of the observed association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449286:magnitude [Quantitative Concept]
   753   C1704240:Magnitude [Quantitative Concept]

Phrase: "was"

Phrase: "related to the variance of each study,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0557651:Study [Manufactured Object]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]
   748   C2603343:Study [Research Activity]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "whether"

Phrase: "large studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "different results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "compared with smaller ones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0547044:Smaller [Qualitative Concept]
   770   C0700321:Smaller [Quantitative Concept]
   770   C1707455:Compared [Activity]
   737   C0205447:One [Quantitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.78: Finally, we evaluated whether the summary results were different when the analysis was limited to studies with more intensive efforts to exclude Alzheimers disease from controls (those that clearly performed neuropsychological testing for all controls). 

Phrase: "Finally,"

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "whether"

Phrase: "the summary results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "when"

Phrase: "the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "limited to studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0439801:Limited [Functional Concept]
   790   C0947630:studies [Laboratory Procedure]
   790   C3542948:Limited [Intellectual Product]
   756 E C0557651:Study [Manufactured Object]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]
   756 E C2603343:Study [Research Activity]

Phrase: "with more intensive efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0015264:Effort [Organism Function]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "Alzheimers disease from controls"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   819   C0920467:controls disease [Therapeutic or Preventive Procedure]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "("

Phrase: "those"

Phrase: "that clearly"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "neuropsychological testing for all controls"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0027902:Neuropsychological testing [Diagnostic Procedure]
   781   C1272570:control testing [Indicator, Reagent, or Diagnostic Aid]
   760   C0039593:Testing [Functional Concept]
   760   C0392366:testing [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.79: Previous investigations have alluded to the possibility that the T allele may interact with the APOE*4 allele in conferring susceptibility to Alzheimers disease (7, 9). 

Phrase: "Previous investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261322:Investigations [Health Care Activity]
   827 E C1552578:investigation [Idea or Concept]
   777 E C1517586:Investigational [Qualitative Concept]
   777 E C3245491:investigational [Intellectual Product]

Phrase: "have"

Phrase: "alluded to the possibility"

Phrase: "that"

Phrase: "the T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "may"

Phrase: "interact with the APOE*4 allele"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   800   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   770   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0002085:Allele [Gene or Genome]
   744   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in conferring susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0012655:Susceptibility [Clinical Attribute]
   861   C0220898:Susceptibility [Organism Attribute]
   861   C1264642:Susceptibility [Functional Concept]
   861   C1547045:*Susceptibility [Quantitative Concept]
   789 E C0231204:Susceptible [Functional Concept]
   789 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(7,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.80: Thus, we also evaluated the effect of T allele carriage on the risk of Alzheimers disease separately for APOE*4-positive and APOE*4-negative subjects. 

Phrase: "Thus,"

Phrase: "we also"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the effect of T allele carriage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of Alzheimers disease separately"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "for APOE*4-positive"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0439178:% Positive [Quantitative Concept]
   804   C1446409:Positive [Qualitative Concept]
   804   C1514241:Positive [Finding]
   804   C2825490:Positive [Qualitative Concept]
   771   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   717   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "APOE*4-negative subjects."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   766   C0681850:Subject [Group]
   766   C1550501:{Subject} [Idea or Concept]
   766   C1706203:Subject [Idea or Concept]
   766   C2349001:Subject [Human]
   766   C2697811:Subject [Functional Concept]
   734   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
Processing 00000000.tx.81: Moreover, we evaluated the genetic effect conferred by the presence of APOE*4 separately in subjects carrying the T allele and those not carrying the T allele. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the genetic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "conferred by the presence of APOE*4 separately"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   782   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   760   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0002085:Allele [Gene or Genome]
   739   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "those"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the T allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.82: Odds ratios were combined with fixed and random effects models, as described above. 

Phrase: "Odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "combined with fixed"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205195:Combined [Qualitative Concept]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "random effects models,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0034656:RANDOM [Research Activity]
   827   C0439605:Random [Qualitative Concept]
   827   C1280500:effects [Qualitative Concept]
   827   C3161035:Models [Intellectual Product]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.83: When these data were not reported, we communicated with the primary investigators to obtain this information, whenever possible. 

Phrase: "When"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "communicated with the primary investigators to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0035173:Investigators [Professional or Occupational Group]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0566001:communicated [Finding]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "this information,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "whenever"

Phrase: "possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.84: Analyses were performed with SPSS 11.0 (SPSS, Inc., Chicago, Illinois) and Meta-Analyst (Joseph Lau, Boston, Massachusetts) software. 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed with SPSS 11.0"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(SPSS,"

Phrase: "Inc.,"

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020898:Illinois [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "Meta-Analyst"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0870132:analyst [Professional or Occupational Group]

Phrase: "(Joseph Lau,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024874:Massachusetts [Geographic Area]

Phrase: ")"

Phrase: "software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.85: Whenever there were 0 values in a 2 x 2 table, we added 0.5 to all four cells, so that an odds ratio could be calculated. 

Phrase: "Whenever"

Phrase: "there"

Phrase: "were"

Phrase: "0 values in a 2 x 2 table,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "we"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "0.5 to all four cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0007634:Cells [Cell]
   753   C0205450:Four [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "an odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "calculated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.86: All p values are two tailed.  

Phrase: "All p values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "two tailed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039259:tailed [Body Part, Organ, or Organ Component]
   861   C0205448:Two [Quantitative Concept]
Processing 00000000.tx.87: META-ANALYSIS RESULTS TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  Eligible studies Fourteen studies probing the relation between the CTSD polymorphism and Alzheimers disease susceptibility were identified (619) and are profiled in table 1. 

Phrase: "META-ANALYSIS RESULTS TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   825   C0871511:methods testing [Intellectual Product]
   799   C0022885:laboratory testing [Laboratory Procedure]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]
   777   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Eligible studies Fourteen studies"

Phrase: "probing"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0419358:Probing, NOS [Diagnostic Procedure]
   966 E C0182400:Probe [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "the relation between the CTSD polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0080103:Relation [Family Group]
   748   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "Alzheimers disease susceptibility"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   827   C0220898:Susceptibility [Organism Attribute]
   827   C1264642:Susceptibility [Functional Concept]
   827   C1547045:*Susceptibility [Quantitative Concept]
   755 E C0231204:Susceptible [Functional Concept]
   755 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(619"

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "profiled in table 1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1979963:Profile [Laboratory Procedure]
   737   C2003903:Profile [Functional Concept]
Processing 00000000.tx.88: Two of the eligible studies (6, 15) contained subjects of two different ethnic groups, so a total of 16 separate comparisons were considered. 

Phrase: "Two of the eligible studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "(6,"

Phrase: "15"

Phrase: ")"

Phrase: "contained subjects of two different ethnic groups,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "so"

Phrase: "a total of 16 separate comparisons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.89: There was considerable diversity of ethnic groups. 

Phrase: "There"

Phrase: "was"

Phrase: "considerable diversity of ethnic groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880371:Diversity [Qualitative Concept]
Processing 00000000.tx.90: Eleven studies (615, 19) selected Alzheimers disease cases according to criteria from the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimers Disease and Related Disorders Association (NINCDS-ADRDA), two studies (16, 18) selected Alzhei-mers disease cases according to Diagnostic and Statistical Manual of Mental Disorders: DSM-IIIR and DSM-IV criteria, and one study (17) did not clarify the exact criteria used for the diagnosis of Alzheimers disease. 

Phrase: "Eleven studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(615,"

Phrase: "19"

Phrase: ")"

Phrase: "selected Alzheimers disease cases according to criteria"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "from the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimers Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   860   C0027765:neurological disease [Disease or Syndrome]
   801   C0002395:Alzheimers disease [Disease or Syndrome]
   788   C0012634:Disease [Disease or Syndrome]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Related Disorders Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(NINCDS-ADRDA"

Phrase: ")"

Phrase: ","

Phrase: "two studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(16,"

Phrase: "18"

Phrase: ")"

Phrase: "selected Alzhei-mers disease cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "according to Diagnostic and Statistical Manual of Mental Disorders"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C1136324:Diagnostic and Statistical Manual of Mental Disorders [Intellectual Product]
   877   C0599833:Diagnostic and Statistical Manual [Intellectual Product]
   818   C0004936:Mental disorders [Mental or Behavioral Dysfunction]
   795   C0011900:Diagnostic [Finding]
   795   C0012634:Disorders [Disease or Syndrome]
   795   C0024763:Manual [Intellectual Product,Manufactured Object]
   795   C0038215:Statistical [Occupation or Discipline]
   795   C0175674:Manual [Functional Concept]
   795   C0229992:mental [Mental Process]
   795   C0348026:Diagnostic [Functional Concept]
   785 E C0033975:mental disorder [Mental or Behavioral Dysfunction]
   768 E C0152097:diaphragm disorders [Disease or Syndrome]
   760 E C0277577:PSYCHIC DISORDER [Mental or Behavioral Dysfunction]
   712 E C0229993:Psychic [Functional Concept]

Phrase: ":"

Phrase: "DSM-IIIR"

Phrase: "and"

Phrase: "DSM-IV criteria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243161:criteria [Intellectual Product]
   734   C0220952:DSM-IV [Intellectual Product]

Phrase: "and"

Phrase: "one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(17"

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the exact criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "used for the diagnosis of Alzheimers disease."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0002395:Alzheimers disease [Disease or Syndrome]
   757   C1524063:Use of [Functional Concept]
   748   C0011900:Diagnosis [Finding]
   748   C0012634:Disease [Disease or Syndrome]
   748   C1273517:used [Finding]
   748   C1704338:diagnosis [Qualitative Concept]
   748   C1704656:DIAGNOSIS [Research Activity]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.91: Five studies (1317) also included autopsy-confirmed Alzheimers disease cases. 

Phrase: "Five studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(1317"

Phrase: ")"

Phrase: "also included autopsy-confirmed Alzheimers disease cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0868928:Cases [Functional Concept]
   795   C1533148:Cases [Quantitative Concept]
   762 E C1706255:CASE [Medical Device]
   762 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.92: Two studies (7, 16) mentioned that they included cases with a family history of Alzheimers disease, eight studies (914, 18, 19) specifically excluded such patients, and the remaining did not clarify the background of family history. 

Phrase: "Two studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(7,"

Phrase: "16"

Phrase: ")"

Phrase: "mentioned"

Phrase: "that"

Phrase: "they"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cases with a family history of Alzheimers disease,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C0085970:cases history [Intellectual Product]
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "eight studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(914,"

Phrase: "18,"

Phrase: "19"

Phrase: ")"

Phrase: "specifically"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "such patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "the remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527428:Remaining [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the background of family history."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0237490:family background [Finding]
   760   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.93: One study (6) mentioned that 61 percent of Alzheimers disease cases had late-onset disease (age of onset: >65 years), five studies (8, 1214, 19) specifically included only late-onset Alzheimers disease cases, one study (18) specifically excluded such patients, and the remaining did not clarify the age at onset. 

Phrase: "One study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(6"

Phrase: ")"

Phrase: "mentioned"

Phrase: "that 61 percent of Alzheimers disease cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439165:Percent [Quantitative Concept]

Phrase: "had"

Phrase: "late-onset disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205087:Late [Temporal Concept]
   827   C0332162:Onset [Qualitative Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: ":"

Phrase: ">65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "five studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(8,"

Phrase: "1214,"

Phrase: "19"

Phrase: ")"

Phrase: "specifically"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "only late-onset Alzheimers disease cases,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]
   734   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]

Phrase: "one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(18"

Phrase: ")"

Phrase: "specifically"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "such patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "the remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527428:Remaining [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the age at onset."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]
Processing 00000000.tx.94: Controls did not have a diagnosis of Alzheimers disease, but the amount of additional screening (general physical and neurologic examination, psychiatric interview, neuropsychological testing, blood and cerebrospinal fluid studies, computed tomography scan, and Mini-Mental State Examination score) to exclude Alzheimers disease differed substantially across studies. 

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a diagnosis of Alzheimers disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "but"

Phrase: "the amount of additional screening"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(general physical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031809:Physical [Health Care Activity]
   861   C0205485:Physical [Functional Concept]
   861   C1509143:Physical [Finding]

Phrase: "and"

Phrase: "neurologic examination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027853:Neurologic Examination [Diagnostic Procedure]

Phrase: "psychiatric interview,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0204480:Psychiatric interview [Diagnostic Procedure]
   861   C0021822:Interview [Activity]
   861   C0205487:Psychiatric [Functional Concept]
   861   C0935630:Interview [Intellectual Product]
   789 E C0033872:Psychiatry [Professional or Occupational Group]
   789 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: "neuropsychological testing,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0027902:Neuropsychological testing [Diagnostic Procedure]
   861   C0039593:Testing [Functional Concept]
   861   C0392366:testing [Intellectual Product]
   827 E C0022885:Test [Laboratory Procedure]

Phrase: "blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "cerebrospinal fluid studies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0007806:Cerebrospinal Fluid [Body Substance]
   734   C0007807:cerebrospinal fluid [Functional Concept]

Phrase: "computed tomography scan,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0040405:computed tomography [Diagnostic Procedure]
           tomography
   901   C1552357:Computed Tomography [Professional or Occupational Group]
   827   C0034606:Scan [Diagnostic Procedure]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0441633:Scan [Diagnostic Procedure]
   827   C1441526:Computed [Laboratory Procedure]
   827   C1880157:Computed [Activity]
   827   C2826292:SCAN [Finding]

Phrase: "and"

Phrase: "Mini-Mental State Examination score"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2960235:Mini-mental state examination score [Finding]
   933   C1532985:Mini mental state score [Intellectual Product]
   804   C0449820:Score [Quantitative Concept]
   771   C0451306:Mini-mental state examination [Diagnostic Procedure]
   717   C0850338:mental state examination [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "differed"

Phrase: "substantially across studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]
Processing 00000000.tx.95: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.96: Characteristics of studies included in the meta-analysis  Specific matching for age was described in five studies (10, 1215). 

Phrase: "Characteristics of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C1568011:Study Characteristics [Intellectual Product]
   790   C1521970:Characteristics [Qualitative Concept]

Phrase: "included in the meta-analysis  Specific matching"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   778   C0282458:Meta-Analysis [Intellectual Product]
   778   C0920317:Meta-Analysis [Research Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0150103:MATCHING [Research Activity]
   748   C0205369:Specific [Qualitative Concept]
   748   C0332257:included [Functional Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1042496:Meta [Eukaryote]
   748   C1524024:analysis [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1708943:Matching [Qualitative Concept]
   748   C3538986:INCLUDED [Gene or Genome]
   714 E C1552866:include [Idea or Concept]
   714 E C2700399:Include [Activity]

Phrase: "for age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "described in five studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205451:Five [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1552738:described [Idea or Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "(10,"

Phrase: "1215"

Phrase: ")."
Processing 00000000.tx.97: One study also matched for sex (10). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "also"

Phrase: "matched for sex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0009253:Sex [Organism Function]
   790   C0036864:Sex [Behavior]
   790   C0079399:sex [Organism Attribute]
   790   C0150103:matched [Research Activity]
   790   C1314687:Sex [Finding]
   790   C1522384:sex [Organism Attribute]
   790   C1708943:Matched [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.98: Only one study (7) specifically mentioned blinding of the personnel who performed the genotyping. 

Phrase: "Only one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "(7"

Phrase: ")"

Phrase: "specifically"

Phrase: "mentioned"

Phrase: "blinding of the personnel"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0024752:personnel [Functional Concept]
   770   C0150108:Blinding [Research Activity]
   770   C0700103:personnel [Quantitative Concept]
   770   C1527117:Personnel [Population Group]
   737 E C0456909:Blind [Disease or Syndrome]
   737 E C0525065:blind [Patient or Disabled Group]

Phrase: "who"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the genotyping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.99: Appropriate molecular methods for genotyping were used. 

Phrase: "Appropriate molecular methods for genotyping"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.100: All studies used polymerase chain reaction, and two studies (14, 18) also used dynamic allele-specific hybridization. 

Phrase: "All"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "used polymerase chain reaction,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "two studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(14,"

Phrase: "18"

Phrase: ")"

Phrase: "also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dynamic allele-specific hybridization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.101: Meta-analysis database The eligible studies summarized in table 2 included a total of 3,175 cases with Alzheimers disease and 3,334 controls, of whom 3,174 and 3,298, respectively, had genotype data. 

Phrase: "Meta-analysis database"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0242356:Database [Intellectual Product]
   827   C0993637:Data Base [Intellectual Product]
   734   C0282458:Meta-Analysis [Intellectual Product]
   734   C0920317:Meta-Analysis [Research Activity]

Phrase: "The eligible studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "summarized in table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a total of 3,175 cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "with Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "3,334 controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "of whom 3,174"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "3,298,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "respectively,"

Phrase: "had"

Phrase: "genotype data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.102: The T allele was more highly represented among controls of American descent (overall prevalence of 8.6 percent, 95 percent confidence interval (CI): 7.1, 10.1) than in controls of European (7.8 percent, 95 percent CI: 7.0, 8.6) or Asian (0.9 percent, 95 percent CI: 0.3, 1.5) descent. 

Phrase: "The T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "was"

Phrase: "more highly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0205250:Highly [Qualitative Concept]

Phrase: "represented among controls of American descent"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0596070:American [Population Group]
   753   C0680043:descent [Family Group]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882932:Represent [Activity]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "(overall prevalence of 8.6 percent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "95 percent confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: "(CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: ":"

Phrase: "7.1,"

Phrase: "10.1"

Phrase: ")"

Phrase: "than"

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "of European"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0239307:European [Population Group]
  1000   C1535514:European [Population Group]

Phrase: "(7.8 percent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "7.0,"

Phrase: "8.6"

Phrase: ")"

Phrase: "or"

Phrase: "Asian"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078988:Asian [Population Group]

Phrase: "(0.9 percent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.3,"

Phrase: "1.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "descent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680043:descent [Family Group]
Processing 00000000.tx.103: There was significant heterogeneity in the prevalence rates of the T allele even across the control subjects of European descent, with a rate of 14.3 percent among Hispanic Americans, 10.4 percent in Italy, 10.1 percent in Spain, and lower rates in northern European countries (7.6 percent in the United Kingdom, 6.3 percent in Sweden, 6.1 percent in Germany, and the lowest prevalence rate of 4.5 percent in a Polish population). 

Phrase: "There"

Phrase: "was"

Phrase: "significant heterogeneity in the prevalence rates of the T allele even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0019409:Heterogeneity [Qualitative Concept]
   712   C2986469:Allelic Heterogeneity [Qualitative Concept]

Phrase: "across the control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "of European descent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680043:descent [Family Group]

Phrase: "with a rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of 14.3 percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "among Hispanic Americans,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019576:Hispanic Americans [Population Group]
           Hispanic
   861   C0086409:Hispanic [Population Group]
   861   C0596070:americans [Population Group]

Phrase: "10.4 percent in Italy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: "10.1 percent in Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: "and"

Phrase: "lower rates in northern European countries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "(7.6 percent in the United Kingdom,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439165:Percent [Quantitative Concept]

Phrase: "6.3 percent in Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: "6.1 percent in Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439165:Percent [Quantitative Concept]

Phrase: "and"

Phrase: "the lowest prevalence rate of 4.5 percent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C1518029:Low Prevalence [Quantitative Concept]
   744   C0033105:Prevalence [Quantitative Concept]
   744   C0220900:prevalence [Quantitative Concept]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "in a Polish population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220896:Polish population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: ")."
Processing 00000000.tx.104: Overall, the prevalence of T/T homozygosity was 0.3 percent, 0.8 percent, and 0.2 percent in control subjects of American, European, and Asian descent, respectively. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "the prevalence of T/T homozygosity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033105:Prevalence [Quantitative Concept]
   753   C0220900:prevalence [Quantitative Concept]

Phrase: "was"

Phrase: "0.3 percent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "0.8 percent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "and"

Phrase: "0.2 percent in control subjects of American,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439165:Percent [Quantitative Concept]

Phrase: "European,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0239307:European [Population Group]
  1000   C1535514:European [Population Group]

Phrase: "and"

Phrase: "Asian descent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680043:descent [Family Group]

Phrase: "respectively."
Processing 00000000.tx.105: The respective prevalence rates of C/T heterozygosity were 16.6 percent, 14.0 percent, and 1.5 percent, and the respective rates for C/C homozygosity were 83.1 percent, 85.2 percent, and 98.3 percent. 

Phrase: "The respective prevalence rates of C/T heterozygosity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0033105:Prevalence [Quantitative Concept]
   744   C0220900:prevalence [Quantitative Concept]
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "16.6 percent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "14.0 percent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "and"

Phrase: "1.5 percent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439165:Percent [Quantitative Concept]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "and"

Phrase: "the respective rates for C/C homozygosity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "83.1 percent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "85.2 percent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]

Phrase: "and"

Phrase: "98.3 percent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439165:Percent [Quantitative Concept]
Processing 00000000.tx.106: The distribution of genotypes in control groups was consistent with Hardy-Weinberg equilibrium in all studies. 

Phrase: "The distribution of genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in control groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0009932:Control Groups [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "consistent with Hardy-Weinberg equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in all studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]
Processing 00000000.tx.107: View this table: [in this window] [in a new window]  TABLE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.108: Distribution of CTSD alleles among Alzheimers disease cases and controls in the included studies  Overall effects There was a trend suggesting that the T allele may confer increased susceptibility to Alzheimers disease (figure 1). 

Phrase: "Distribution of CTSD alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "among Alzheimers disease cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "and"

Phrase: "controls in the included studies  Overall effects There"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   744   C0243148:control [Qualitative Concept]
   744   C0282416:Overall [Intellectual Product]
   744   C0332257:included [Functional Concept]
   744   C0947630:studies [Laboratory Procedure]
   744   C1280500:effects [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1561607:Overall [Qualitative Concept]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   744   C3538986:INCLUDED [Gene or Genome]
   711 E C0557651:Study [Manufactured Object]
   711 E C2348382:Effect [Qualitative Concept]
   711 E C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "a trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521798:trend [Temporal Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "may"

Phrase: "confer"

Phrase: "increased susceptibility to Alzheimers disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "(figure 1"

Phrase: ")."
Processing 00000000.tx.109: As shown in table 3, the summary odds ratio was 1.17 by random effects (p = 0.14), and there was significant heterogeneity among the 16 study comparisons (p < 0.01 for heterogeneity). 

Phrase: "As"

Phrase: "shown in table 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "the summary odds ratio"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]
   827   C1552616:summary [Intellectual Product]
   827   C1706244:Summary [Intellectual Product]

Phrase: "was"

Phrase: "1.17 by random effects"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034656:RANDOM [Research Activity]
   760   C0439605:Random [Qualitative Concept]
   760   C1280500:effects [Qualitative Concept]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "(p = 0.14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "significant heterogeneity among the 16 study comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "(p < 0.01 for heterogeneity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0019409:Heterogeneity [Qualitative Concept]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.110: We found no evidence of an association of the T/T genotype with the risk of Alzheimers disease relative to the C/C genotype. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence of an association of the T/T genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "relative to the C/C genotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.111: There was no significant between-study heterogeneity. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant between-study heterogeneity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.112: No evidence of an association with Alzhei-mers disease was discerned also when the recessive model was examined for the effect of T, while a trend for an association was seen in the dominant model (by random effects, OR = 1.19, 95 percent CI: 0.97, 1.47; 

Phrase: "No evidence of an association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with Alzhei-mers disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "discerned"

Phrase: "also"

Phrase: "when"

Phrase: "the recessive model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "examined for the effect of T,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332128:Examined [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "while"

Phrase: "a trend for an association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521798:trend [Temporal Concept]

Phrase: "was"

Phrase: "seen in the dominant model"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205397:Seen [Qualitative Concept]
   760   C1527180:Dominant [Functional Concept]
   760   C3161035:Model [Intellectual Product]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "("

Phrase: "by random effects,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0034656:RANDOM [Research Activity]
   861   C0439605:Random [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.19,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "1.47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.113: p = 0.10). 

Phrase: "p = 0.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.114: There was no between-study heterogeneity in the recessive model contrast, while significant heterogeneity (p < 0.05) was still seen for the dominant model contrast. 

Phrase: "There"

Phrase: "was"

Phrase: "no between-study heterogeneity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0019409:Heterogeneity [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C1298908:no [Idea or Concept]
   770   C1549444:No [Idea or Concept]
   770   C2603343:Study [Research Activity]

Phrase: "in the recessive model contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1979874:Contrast [Qualitative Concept]

Phrase: "while"

Phrase: "significant heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "still"

Phrase: "seen for the dominant model contrast."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0205397:Seen [Qualitative Concept]
   753   C1527180:Dominant [Functional Concept]
   753   C1979874:Contrast [Qualitative Concept]
   753   C3161035:Model [Intellectual Product]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]
Processing 00000000.tx.115: Subgroup analysis of studies with cases and controls of European descent yielded similar results (15 comparisons (11,436 alleles): OR = 1.18, 95 percent CI: 0.96, 1.46; 

Phrase: "Subgroup analysis of studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls of European"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0239307:European [Population Group]
   790   C0243148:control [Qualitative Concept]
   790   C1535514:European [Population Group]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "descent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680043:descent [Family Group]

Phrase: "yielded similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "(15 comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "(11,436 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.18,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.96,"

Phrase: "1.46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.116: p = 0.12) (p < 0.01 for heterogeneity). 

Phrase: "p = 0.12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(p < 0.01 for heterogeneity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0019409:Heterogeneity [Qualitative Concept]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.117: View larger version (26K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.118: Meta-analysis for the effect of the T allele versus the C allele on the risk of Alzheimers disease. 

Phrase: "Meta-analysis for the effect of the T allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0282458:Meta-Analysis [Intellectual Product]
   764   C0920317:Meta-Analysis [Research Activity]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1042496:Meta [Eukaryote]
   742   C1524024:analysis [Functional Concept]

Phrase: "versus"

Phrase: "the C allele on the risk of Alzheimers disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.119: Each comparison is presented by the name of the first author and the year of publication. 

Phrase: "Each comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "is"

Phrase: "presented by the name of the first author"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   767   C0805191:Author name [Intellectual Product]
   767   C1443235:First Name [Organism Attribute]
   767   C1716526:First name [Clinical Attribute]
   744   C0027365:Name [Intellectual Product]
   744   C0205435:First [Quantitative Concept]
   744   C0221193:Author [Professional or Occupational Group]
   744   C0449450:Presented [Idea or Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1547383:Name [Intellectual Product]
   711 E C0150312:Present [Quantitative Concept]

Phrase: "and"

Phrase: "the year of publication."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439234:year [Temporal Concept]
   770   C0439508:/year [Temporal Concept]
Processing 00000000.tx.120: "H" signifies Hispanic subjects, and "J" signifies Japanese subjects. 

Phrase: """H"""
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "signifies"

Phrase: "Hispanic subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and """

Phrase: "J"""

Phrase: "signifies"

Phrase: "Japanese subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.121: For each comparison, the point estimate of the odds ratio and the accompanying 95% confidence interval (CI) are shown. 

Phrase: "For each comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "the point estimate of the odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0750572:Estimate [Quantitative Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "the accompanying 95% confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: "(CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.122: "ALL" represents the summary random-effects estimate for the comparison along with the respective 95% confidence interval. 

Phrase: """"

Phrase: "ALL"""

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the summary random-effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0034656:RANDOM [Research Activity]
   827   C0439605:Random [Qualitative Concept]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "estimate for the comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0750572:Estimate [Quantitative Concept]
   770   C1707455:Comparison [Activity]

Phrase: "along with the respective 95% confidence interval."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]
Processing 00000000.tx.123: Values above 1 denote an increased risk for Alzheimers disease with the T allele.  

Phrase: "Values above 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "denote"

Phrase: "an increased risk for Alzheimers disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   737   C0277564:Acquired disease [Disease or Syndrome]

Phrase: "with the T allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.124: View this table: [in this window] [in a new window]  TABLE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.125: Summary odds ratios for various contrasts  Bias diagnostics In cumulative meta-analysis and recursive cumulative meta-analysis, the magnitude of the summary odds ratio had not been stable over time, and it had changed considerably per year with an apparent dissipation of the postulated effect (by random effects, summary OR for T vs. 

Phrase: "Summary odds ratios for various contrasts"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1552616:summary [Intellectual Product]
   753   C1610540:*Ratios [Quantitative Concept]
   753   C1706244:Summary [Intellectual Product]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "Bias"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]

Phrase: "diagnostics In cumulative meta-analysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0011900:Diagnostic [Finding]
   726   C0348026:Diagnostic [Functional Concept]

Phrase: "and"

Phrase: "recursive cumulative meta-analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0282458:Meta-Analysis [Intellectual Product]
   861   C0920317:Meta-Analysis [Research Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1042496:Meta [Eukaryote]
   812   C1524024:analysis [Functional Concept]

Phrase: "the magnitude of the summary odds ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449286:magnitude [Quantitative Concept]
   748   C1704240:Magnitude [Quantitative Concept]

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "stable over time,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205360:Stable [Qualitative Concept]
   790   C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "it"

Phrase: "had"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "considerably per year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439234:year [Temporal Concept]
   790   C0439508:/year [Temporal Concept]

Phrase: "with an apparent dissipation"

Phrase: "of the postulated effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "by random effects,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0034656:RANDOM [Research Activity]
   861   C0439605:Random [Qualitative Concept]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "summary OR for T"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0028873:Odds Ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
   760   C1552616:summary [Intellectual Product]
   760   C1706244:Summary [Intellectual Product]

Phrase: "vs."
Processing 00000000.tx.126: C: 2.05 at the end of 1999, 1.41 at the end of 2000, 1.16 at the end of 2001, 1.14 at the end of 2002, and 1.17 in 2003). 

Phrase: "C"

Phrase: ":"

Phrase: "2.05 at the end of 1999,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0444930:End [Spatial Concept]
   748   C0740116:+2 [Quantitative Concept]
   748   C2746065:End [Temporal Concept]
   748   C2827735:2+ [Quantitative Concept]
   748   C2981700:2+ [Classification]

Phrase: "1.41 at the end of 2000,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0444930:End [Spatial Concept]
   748   C2746065:End [Temporal Concept]
   748   C2827734:1+ [Quantitative Concept]
   748   C2981698:1+ [Classification]

Phrase: "1.16 at the end of 2001,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0444930:End [Spatial Concept]
   748   C2746065:End [Temporal Concept]
   748   C2827734:1+ [Quantitative Concept]
   748   C2981698:1+ [Classification]

Phrase: "1.14 at the end of 2002,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0444930:End [Spatial Concept]
   748   C2746065:End [Temporal Concept]
   748   C2827734:1+ [Quantitative Concept]
   748   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1.17 in 2003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.127: Excluding the first hypothesis-generating study (9), we found that the summary odds ratio became 1.11 (95 percent CI: 0.91, 1.35; 

Phrase: "Excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the first hypothesis-generating study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the summary odds ratio"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]
   827   C1552616:summary [Intellectual Product]
   827   C1706244:Summary [Intellectual Product]

Phrase: "became"

Phrase: "1.11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.91,"

Phrase: "1.35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.128: p = 0.29) with significant between-study heterogeneity (p < 0.05), and there was no evidence of any association even in the comparison of the homozygotes (T/T vs. 

Phrase: "p = 0.29"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "with significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "between-study heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "no evidence of any association even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "of the homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygotes [Organism Attribute]

Phrase: "(T/T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.129: C/C: OR = 0.96, 95 percent CI: 0.48, 1.90; 

Phrase: "C/C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ":"

Phrase: "OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 0.96,"

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.48,"

Phrase: "1.90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.130: p = 0.91), with no between-study heterogeneity. 

Phrase: "p = 0.91"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "with no between-study heterogeneity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0019409:Heterogeneity [Qualitative Concept]
   743 E C1512426:Heterogenous [Idea or Concept]
Processing 00000000.tx.131: There was no relation between the effect size and the variance of each study, suggesting that larger studies agreed with the results of smaller studies. 

Phrase: "There"

Phrase: "was"

Phrase: "no relation between the effect size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0080103:Relation [Family Group]
   753   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "the variance of each study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1711260:Variance [Qualitative Concept]
   760   C2348152:Variance [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that larger studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "agreed with the results of smaller studies."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   774   C0683954:results studies [Finding]
   748   C0547044:Smaller [Qualitative Concept]
   748   C0700321:Smaller [Quantitative Concept]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714 E C2603343:Study [Research Activity]
   714   C2825142:Result [Finding]
   714   C3641827:Agree [Intellectual Product]
Processing 00000000.tx.132: Analyses limited to studies with more intensive efforts to exclude Alzheimers disease from controls yielded similar results (11 comparisons (10,382 alleles): OR = 1.22, 95 percent CI: 0.96, 1.54; 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "limited to studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0439801:Limited [Functional Concept]
   790   C0947630:studies [Laboratory Procedure]
   790   C3542948:Limited [Intellectual Product]
   756 E C0557651:Study [Manufactured Object]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]
   756 E C2603343:Study [Research Activity]

Phrase: "with more intensive efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0015264:Effort [Organism Function]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "Alzheimers disease from controls"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   819   C0920467:controls disease [Therapeutic or Preventive Procedure]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "yielded"

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "(11 comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "(10,382 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "OR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratio [Quantitative Concept]
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "= 1.22,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.96,"

Phrase: "1.54"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.133: p = 0.10) (p = 0.02 for heterogeneity). 

Phrase: "p = 0.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(p = 0.02 for heterogeneity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0019409:Heterogeneity [Qualitative Concept]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.134: Interaction with the APOE genotype Nine studies (79, 1114, 16, 18) obtained data on both CTSD and APOE genotypes. 

Phrase: "Interaction with the APOE genotype Nine studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "(79,"

Phrase: "1114,"

Phrase: "16,"

Phrase: "18"

Phrase: ")"

Phrase: "obtained data on both CTSD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "APOE genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.135: With one study (8) separating male and female subjects, 10 comparisons became available. 

Phrase: "With one study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(8"

Phrase: ")"

Phrase: "separating male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "female subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "10 comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "became"

Phrase: "available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]
Processing 00000000.tx.136: These nine comparative studies tended to gave a slightly inflated effect for the T allele, as compared with the full meta-analysis of 14 comparisons (summary OR by random effects = 1.23 vs. 1.17 for the complete meta-analysis); 

Phrase: "These nine comparative studies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0009491:Comparative Studies [Intellectual Product]
   867 E C1579762:comparative study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "tended to"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a slightly inflated effect for the T allele,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "compared with the full meta-analysis of 14 comparisons"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0282458:Meta-Analysis [Intellectual Product]
   764   C0920317:Meta-Analysis [Research Activity]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0443225:Full [Qualitative Concept]
   742   C0936012:Analysis [Research Activity]
   742   C1042496:Meta [Eukaryote]
   742   C1524024:analysis [Functional Concept]
   742   C1707455:Compared [Activity]
           Comparison

Phrase: "(summary OR by random effects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]
   753   C1552616:summary [Intellectual Product]
   753   C1706244:Summary [Intellectual Product]

Phrase: "= 1.23"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450348:23 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "vs. 1.17 for the complete meta-analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0205197:Complete [Qualitative Concept]
   744   C0725685:COMPLEAT [Food]
   744   C0936012:Analysis [Research Activity]
   744   C1042496:Meta [Eukaryote]
   744   C1524024:analysis [Functional Concept]
   744   C1704629:VS [Idea or Concept]
   744   C1704752:VS [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.137: thus, inferences should be cautious. 

Phrase: "thus,"

Phrase: "inferences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0679201:Inference [Mental Process]

Phrase: "should"

Phrase: "be"

Phrase: "cautious."
Processing 00000000.tx.138: Among carriers of the high-risk APOE*4 allele, T allele carriers had a random-effects odds ratio of 1.38 (95 percent CI: 0.89, 2.15) for Alzheimers disease compared with subjects not carrying the T allele. 

Phrase: "Among carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "of the high-risk APOE*4 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]

Phrase: "T allele carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0007294:carriers [Finding]
   793 E C0560175:Carrier [Finding]
   793 E C1706209:Carrier [Medical Device]
   793 E C3273162:Carrier [Intellectual Product]

Phrase: "had"

Phrase: "a random-effects odds ratio of 1.38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028873:Odds Ratio [Quantitative Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.89,"

Phrase: "2.15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "for Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "compared with subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the T allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.139: Among subjects not carrying the APOE*4 allele, the respective odds ratio was 1.13 (95 percent CI: 0.90, 1.42). 

Phrase: "Among subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the APOE*4 allele,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   717   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "the respective odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "1.13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "0.90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "1.42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.140: There was significant between-study heterogeneity in the APOE*4-positive group (p = 0.07). 

Phrase: "There"

Phrase: "was"

Phrase: "significant between-study heterogeneity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "in the APOE*4-positive group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0441833:Group [Idea or Concept]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   734   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]

Phrase: "(p = 0.07"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.141: The two effect sizes overlapped widely. 

Phrase: "The two effect sizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0814843:effect sizes [Quantitative Concept]
   827   C0456389:SIZES [Spatial Concept]

Phrase: "overlapped"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0185027:overlapped [Therapeutic or Preventive Procedure]
   966 E C1948020:Overlap [Conceptual Entity]

Phrase: "widely."
Processing 00000000.tx.142: Among carriers of the T allele, the presence of APOE*4 increased the risk of Alzheimers disease 6.07-fold (95 percent CI: 4.19, 8.79), with no between-study heterogeneity. 

Phrase: "Among carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "of the T allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "the presence of APOE*4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of Alzheimers disease 6.07-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1281905:disease risk [Finding]
   744   C0035647:Risk [Qualitative Concept]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "4.19,"

Phrase: "8.79"

Phrase: ")"

Phrase: ","

Phrase: "with no between-study heterogeneity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0019409:Heterogeneity [Qualitative Concept]
   743 E C1512426:Heterogenous [Idea or Concept]
Processing 00000000.tx.143: Among subjects without the T allele, the presence of APOE*4 increased the risk of Alzheimers disease 4.09-fold (95 percent CI: 3.15, 5.31), with significant between-study heterogeneity (p < 0.01). 

Phrase: "Among subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "without the T allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "the presence of APOE*4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of Alzheimers disease 4.09-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1281905:disease risk [Finding]
   744   C0035647:Risk [Qualitative Concept]

Phrase: "(95 percent CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: ":"

Phrase: "3.15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "5.31"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439084:>5 [Quantitative Concept]
   861   C0450355:31 [Intellectual Product]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "with significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "between-study heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.144: The two estimates overlapped widely in individual studies and overall, but typically the odds ratios were larger in the group of T allele carriers (figure 2). 

Phrase: "The two estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750572:estimates [Quantitative Concept]

Phrase: "overlapped"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0185027:overlapped [Therapeutic or Preventive Procedure]
   966 E C1948020:Overlap [Conceptual Entity]

Phrase: "widely in individual studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0027361:Individual [Population Group]
   770   C0237401:Individual [Human]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "but"

Phrase: "typically"

Phrase: "the odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0028873:Odds Ratios [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "larger in the group of T allele carriers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0679991:large group [Group Attribute]
   744   C0443228:larger [Quantitative Concept]
   744   C0549177:Larger [Quantitative Concept]
   744   C1704243:Larger [Quantitative Concept]

Phrase: "(figure 2"

Phrase: ")."
Processing 00000000.tx.145: View larger version (22K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.146: Meta-analysis for the effect of the APOE*4 allele in T carriers and in T noncarriers on the risk of Alzheimers disease (AD). 

Phrase: "Meta-analysis for the effect of the APOE*4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0282458:Meta-Analysis [Intellectual Product]
   753   C0920317:Meta-Analysis [Research Activity]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1042496:Meta [Eukaryote]
   736   C1524024:analysis [Functional Concept]

Phrase: "in T carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "and in T noncarriers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   737   C2986416:Noncarrier [Conceptual Entity]

Phrase: "on the risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "of Alzheimers disease (AD)."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.147: Each comparison is presented by the name of the first author. 

Phrase: "Each comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "is"

Phrase: "presented by the name of the first author."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   767   C0805191:Author name [Intellectual Product]
   767   C1443235:First Name [Organism Attribute]
   767   C1716526:First name [Clinical Attribute]
   744   C0027365:Name [Intellectual Product]
   744   C0205435:First [Quantitative Concept]
   744   C0221193:Author [Professional or Occupational Group]
   744   C0449450:Presented [Idea or Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1547383:Name [Intellectual Product]
   711 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.148: "M" signifies male subjects, and "F" signifies female subjects. 

Phrase: """"

Phrase: "M"""

Phrase: "signifies"

Phrase: "male subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and """

Phrase: "F"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "signifies"

Phrase: "female subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.149: For each comparison, the point estimate of the odds ratio and the accompanying 95% confidence interval (CI) are shown. 

Phrase: "For each comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "the point estimate of the odds ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0750572:Estimate [Quantitative Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "the accompanying 95% confidence interval"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]

Phrase: "(CI"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009667:Confidence Interval [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.150: Filled squares represent T carriers, while open circles represent T noncarriers. 

Phrase: "Filled squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "T carriers,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0007294:carriers [Finding]
   827 E C0560175:Carrier [Finding]
   827 E C1706209:Carrier [Medical Device]
   827 E C3273162:Carrier [Intellectual Product]

Phrase: "while"

Phrase: "open circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "T noncarriers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2986416:Noncarrier [Conceptual Entity]
Processing 00000000.tx.151: "ALL" represents the summary random-effects estimate for the comparison along with the respective 95% confidence interval. 

Phrase: """"

Phrase: "ALL"""

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the summary random-effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0034656:RANDOM [Research Activity]
   827   C0439605:Random [Qualitative Concept]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "estimate for the comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0750572:Estimate [Quantitative Concept]
   770   C1707455:Comparison [Activity]

Phrase: "along with the respective 95% confidence interval."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009667:Confidence Interval [Quantitative Concept]
   812   C0237529:Confidence [Mental Process]
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
   812   C1704725:Confidence [Qualitative Concept]
   812   C1704726:Confidence [Mental Process]
   741 E C0558095:Confident [Individual Behavior]
   712 E C0009669:confidentiality [Idea or Concept]
Processing 00000000.tx.152: Papassotiropoulos-2 and -1 pertain to the following respective references: (7, 9).   

Phrase: "Papassotiropoulos-2"

Phrase: "and -"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "pertain to the following respective references"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C0332283:follow [Temporal Concept]
   719   C1514811:Reference [Idea or Concept]
   719   C1706462:Reference [Conceptual Entity]
   719   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "(7,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.153: DISCUSSION TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  This meta-analysis includes data from 14 case-control studies with over 6,000 genotyped Alzheimers disease cases and controls, and it proves that the CTSD polymorphism is not a strong risk factor for Alzheimers disease. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   831   C0871511:methods testing [Intellectual Product]
   801   C0022885:laboratory testing [Laboratory Procedure]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]
   779   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "data from 14 case-control studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681873:study data [Research Activity]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "with over 6,000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205136:Over [Spatial Concept]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "Alzheimers disease cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "and"

Phrase: "controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "proves"

Phrase: "that"

Phrase: "the CTSD polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a strong risk factor for Alzheimers disease."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.154: The current evidence cannot exclude that the T allele of the CTSD polymorphism may increase modestly the risk of Alzheimers disease, but there was significant heterogeneity in the results of various studies. 

Phrase: "The current evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "that"

Phrase: "the T allele of the CTSD polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Allele [Gene or Genome]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "modestly"

Phrase: "the risk of Alzheimers disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "but"

Phrase: "there"

Phrase: "was"

Phrase: "significant heterogeneity in the results of various studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019409:Heterogeneity [Qualitative Concept]
Processing 00000000.tx.155: However, we found that bias might exist, with a decreasing effect size, as more data accumulated over time. 

Phrase: "However,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]
   966 E C1061346:Bia [Eukaryote]
   966 E C1704746:BIA [Diagnostic Procedure]

Phrase: "might"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "with a decreasing effect size,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0814843:effect size [Quantitative Concept]
   827   C0456389:size [Spatial Concept]

Phrase: "as"

Phrase: "more data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "accumulated over time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.156: Moreover, the meta-analysis also cannot exclude the possibility that the presence of the CTSD T allele may enhance the increased susceptibility toward Alzheimers disease conferred by APOE*4. 

Phrase: "Moreover,"

Phrase: "the meta-analysis also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the presence of the CTSD T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the increased susceptibility toward Alzheimers disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "conferred by APOE*4."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   833   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   790   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002085:Allele [Gene or Genome]
   753   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.157: However, even if this is true, it would pertain to the relatively small group of subjects who carry both the APOE*4 and CTSD T alleles. 

Phrase: "However,"

Phrase: "even"

Phrase: "if"

Phrase: "this"

Phrase: "is"

Phrase: "true,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205238:True [Qualitative Concept]

Phrase: "it"

Phrase: "would"

Phrase: "pertain to the relatively small group of subjects"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0679993:small group [Group Attribute]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C0700321:Small [Quantitative Concept]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "both the APOE*4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   812   C0002085:Allele [Gene or Genome]
   756   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "CTSD T alleles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002085:Alleles [Gene or Genome]
   708   C0054875:cathepsin T [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.158: In all, the impact of the T allele on a population level would be small, if present at all. 

Phrase: "In all,"

Phrase: "the impact of the T allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "on a population level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0032659:Population [Quantitative Concept]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1257890:Population [Population Group]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "would"

Phrase: "be"

Phrase: "small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "if"

Phrase: "present at all."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
Processing 00000000.tx.159: The meta-analysis findings may be interpreted against the postulated biologic context of the CTSD polymorphism. 

Phrase: "The meta-analysis findings"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]
   734   C0282458:Meta-Analysis [Intellectual Product]
   734   C0920317:Meta-Analysis [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "interpreted against the postulated biologic context of the CTSD polymorphism."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1332805:CATHEPSIN D [Gene or Genome]
   738   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0032529:Polymorphism [Genetic Function]
   738   C0205460:Biologic [Qualitative Concept]
   738   C0449255:Context [Finding]
   738   C0542559:Context [Functional Concept]
   738   C1285553:interpreted [Functional Concept]
   738   C1882417:Polymorphism [Qualitative Concept]
   738   C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.160: Cathepsin D is an intracellular acid protease with beta-secretase activity in vitro (1, 2) that can cleave amyloid precursor protein and the tau protein to generate fragments with intact microtubule-binding domains (44), which might play a role in the pathogenesis of paired helical filaments. 

Phrase: "Cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an intracellular acid protease with beta-secretase activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1150095:protease activity [Molecular Function]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C1947941:Protease [Enzyme]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "that"

Phrase: "can"

Phrase: "cleave"

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "the tau protein to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "generate"

Phrase: "fragments with intact microtubule-binding domains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the pathogenesis of paired helical filaments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.161: One study has shown that the CTSD polymorphism is associated with increased secretion and altered intracellular maturation of procathepsin D (3). 

Phrase: "One study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the CTSD polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "is"

Phrase: "associated with increased secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "altered intracellular maturation of procathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0678723:Maturation [Organism Function]
   753   C0870861:maturation [Phenomenon or Process]
   753   C1254042:Maturation [Physiologic Function]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.162: It should be noted that it is not clear whether the CTSD polymorphism has functional consequences for the mature form of the enzyme. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "the CTSD polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "has"

Phrase: "functional consequences for the mature form of the enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0686907:Consequence of [Functional Concept]
           consequences
Processing 00000000.tx.163: Although we cannot exclude a biologic effect for the CTSD polymorphism, our findings are in accordance with the results of a recent full genome scan showing no significant linkage of Alzheimers disease to the short arm of chromosome 11, the region where the CTSD gene is located (4547). 

Phrase: "Although"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "a biologic effect for the CTSD polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are in accordance with the results of a recent full genome scan"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C1517519:Genome Scan [Molecular Biology Research Technique]
   751   C1548201:Full results [Idea or Concept]
   736   C0017428:Genome [Gene or Genome]
   736   C0034606:Scan [Diagnostic Procedure]
   736   C0332185:Recent [Temporal Concept]
   736   C0441633:Scan [Diagnostic Procedure]
   736   C0443225:Full [Qualitative Concept]
   736   C1551058:Are [Quantitative Concept]
   736   C2338314:Genome [Conceptual Entity]
   736   C2826292:SCAN [Finding]
   703   C1274040:Result [Functional Concept]
   703   C1546471:Result [Idea or Concept]
   703   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no significant linkage of Alzheimers disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023745:linkage [Molecular Function]

Phrase: "to the short arm"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0426857:Short arm [Finding]
   861   C0446516:Arm [Body Location or Region]
   861   C1269078:Arm [Body Part, Organ, or Organ Component]
   861   C1269612:Arm [Body Location or Region]
   861   C1282927:short [Qualitative Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   805 E C0445456:Brachial [Spatial Concept]
   777 E C0206655:ARMS [Neoplastic Process]
   777 E C2681631:ARMS [Gene or Genome]

Phrase: "of chromosome 11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008653:Chromosome 11 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "the region where"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "the CTSD gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "is"

Phrase: "located"

Phrase: "(4547"

Phrase: ")."
Processing 00000000.tx.164: Attention should be given to the design of individual studies. 

Phrase: "Attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]

Phrase: "should"

Phrase: "be"

Phrase: "given to the design of individual studies."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   757   C0035171:Study Design [Research Activity]
   757   C2983265:Study Design [Intellectual Product]
           DESIGN
   757   C2986888:Study Design [Research Activity]
   748   C0027361:Individual [Population Group]
   748   C0237401:Individual [Human]
   748   C0947630:studies [Laboratory Procedure]
   748   C1442162:GIVEN [Conceptual Entity]
   748   C1550718:given [Idea or Concept]
   748   C1707689:Design [Activity]
   748   C3244317:given [Intellectual Product]
   714 E C0557651:Study [Manufactured Object]
   714 E C1947971:Give [Functional Concept]
   714 E C2603343:Study [Research Activity]
Processing 00000000.tx.165: The results of meta-analyses may be affected by methodological problems and potential biases in the designs of the constituent studies. 

Phrase: "The results of meta-analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "affected by methodological problems"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1546466:Problems [Idea or Concept]
   737 E C0001721:Affect [Mental Process]
   737 E C0033213:Problem [Finding]

Phrase: "and"

Phrase: "potential biases in the designs of the constituent studies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0242568:Biases [Idea or Concept]
   708 E C1504315:Bias [Bird]
Processing 00000000.tx.166: Nondifferential misclassification errors may dilute the strength of an observed association. 

Phrase: "Nondifferential misclassification errors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0743559:errors [Qualitative Concept]
   793 E C1608199:Error [Functional Concept]

Phrase: "may"

Phrase: "dilute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720119:Dilute [Functional Concept]
  1000   C1948037:Dilute [Functional Concept]

Phrase: "the strength of an observed association."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237897:Strength [Quantitative Concept]
   753   C0808080:Strength [Idea or Concept]
   753   C1705922:Strength [Qualitative Concept]
Processing 00000000.tx.167: Alzheimers disease cases were generally selected according to appropriate criteria. 

Phrase: "Alzheimers disease cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "were"

Phrase: "generally"

Phrase: "selected according to appropriate criteria."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243161:criteria [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C1548787:Appropriate [Qualitative Concept]
   726   C1707391:Select [Activity]
Processing 00000000.tx.168: However, some young control subjects may have developed Alzheimers disease at older ages. 

Phrase: "However,"

Phrase: "some young control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "may"

Phrase: "have"

Phrase: "developed Alzheimers disease at older ages."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.169: The choice of an appropriate age window for assessing a postulated genetic risk factor for Alzheimers disease is difficult. 

Phrase: "The choice of an appropriate age window"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0008300:choice [Individual Behavior]
   748   C1707391:Choice [Activity]

Phrase: "for assessing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516048:Assess [Activity]

Phrase: "a postulated genetic risk factor for Alzheimers disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0814299:factor genetic risk [Qualitative Concept]
   793   C0850664:disease risk factor [Finding]
   770   C0035648:Risk factor [Quantitative Concept]
   767   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   767   C0679238:disease factor [Functional Concept]
   767   C0960756:factor A [Organic Chemical]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "difficult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]
Processing 00000000.tx.170: Studies of younger subjects may be more suitable for identifying risk factors that result in early onset Alzhei-mers disease. 

Phrase: "Studies of younger subjects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   786   C0681850:Study Subject [Group]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "more suitable for identifying risk factors"

Phrase: "that"

Phrase: "result in early onset Alzhei-mers disease."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0814120:early disease onset [Disease or Syndrome]
   778   C1833334:Early-onset [Finding]
   774   C0277793:disease onset [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1279919:Early [Temporal Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
Processing 00000000.tx.171: Conversely, selection of younger subjects may be less appropriate, if the influence of the postulated genetic risk factor is more important in late-onset Alzhei-mers disease. 

Phrase: "Conversely,"

Phrase: "selection of younger subjects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C0949543:Selection of Subjects [Research Activity]
           Subjects Selection
   770   C0036576:selection [Genetic Function]

Phrase: "may"

Phrase: "be"

Phrase: "less appropriate,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1548787:Appropriate [Qualitative Concept]
   789 E C0814634:appropriateness [Qualitative Concept]

Phrase: "if"

Phrase: "the influence of the postulated genetic risk factor"

Phrase: "is"

Phrase: "more important in late-onset Alzhei-mers disease."
Processing 00000000.tx.172: Subgroup effects and effect modification (e.g., differential effects of a genetic polymorphism on early vs. late-onset Alzheimers disease cases or familial vs. sporadic disease) or complex interactions with other genes may also need to be considered (48). 

Phrase: "Subgroup effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "effect modification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0392747:Modification [Functional Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C1554963:modification [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "differential effects of a genetic polymorphism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "vs. late-onset Alzheimers disease cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "or"

Phrase: "familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:familial [Family Group]
  1000   C0241888:Familial [Functional Concept]
   928 E C1704727:Family [Conceptual Entity]

Phrase: "vs. sporadic disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "complex interactions with other genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0596610:gene interaction [Genetic Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "may"

Phrase: "also"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.173: Our analyses addressed interactions with APOE*4, the major known genetic determinant of Alzhei-mers disease. 

Phrase: "Our analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "interactions with APOE*4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1704675:Interaction [Functional Concept]
   716   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]

Phrase: "the major known genetic determinant of Alzhei-mers disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.174: Interactions with other genetic or environmental factors have not been studied. 

Phrase: "Interactions with other genetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.175: The trend for a stronger effect of APOE*4 in the presence of T allele carriage is interesting in the light of data suggesting that T carriage may affect the general intelligence (5). 

Phrase: "The trend for a stronger effect of APOE*4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1521798:trend [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of T allele carriage"

Phrase: "is"

Phrase: "interesting in the light of data"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C0543488:interesting [Mental Process]
   753   C1306462:Light [Functional Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1881376:Light [Qualitative Concept]
   753   C3245479:data [Medical Device]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that T carriage"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the general intelligence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021704:Intelligence [Mental Process]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.176: However, subgroup and interaction analyses should be interpreted cautiously, since differences between subgroups may occur by chance (49) and their validation would require studies with even larger sample sizes than the several thousand included in this meta-analysis. 

Phrase: "However,"

Phrase: "subgroup"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1079230:subgroup [Virus]
  1000   C1515021:Subgroup [Classification]

Phrase: "and"

Phrase: "interaction analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0237688:Interaction Analysis [Quantitative Concept]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "should"

Phrase: "be"

Phrase: "interpreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpreted [Functional Concept]

Phrase: "cautiously,"

Phrase: "since"

Phrase: "differences between subgroups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "may"

Phrase: "occur by chance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237506:Chance [Qualitative Concept]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "(49"

Phrase: ")"

Phrase: "and"

Phrase: "their validation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519941:Validation [Research Activity]

Phrase: "would"

Phrase: "require"

Phrase: "studies with even larger sample sizes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "than the several thousand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883310:Thousand [Quantitative Concept]

Phrase: "included in this meta-analysis."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0332257:included [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]
Processing 00000000.tx.177: Finally, population stratification may theoretically have affected the results of the constituent studies in the meta-analysis (50), since we documented that the frequency of the T allele varied considerably among the different ethnic groups or even among the different ethnic groups of European descent. 

Phrase: "Finally,"

Phrase: "population stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514983:Stratification [Research Activity]

Phrase: "may"

Phrase: "theoretically"

Phrase: "have"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the results of the constituent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "studies in the meta-analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0282458:Meta-Analysis [Intellectual Product]
   806   C0920317:Meta-Analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0557651:Study [Manufactured Object]
   760   C0936012:Analysis [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C1042496:Meta [Eukaryote]
   760   C1524024:analysis [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "since"

Phrase: "we"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "that"

Phrase: "the frequency of the T allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "varied"

Phrase: "considerably among the different ethnic groups"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   756 E C1879937:Ethnic Group [Intellectual Product]
   753   C0441833:Group [Idea or Concept]
   753   C0680174:ethnic [Finding]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   748   C0682076:ethnic difference [Finding]

Phrase: "or"

Phrase: "even among the different ethnic groups of European descent."
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   764   C0015031:Ethnic Groups [Population Group]
           ETHNIC
   762   C0239307:ethnic european [Population Group]
           European
   742   C0441833:Group [Idea or Concept]
   742   C0680043:descent [Family Group]
   742   C0680174:ethnic [Finding]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1535514:European [Population Group]
   742   C1552516:Group [Health Care Related Organization]
   742   C1552839:groups [Idea or Concept]
   742   C1705242:Different [Qualitative Concept]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]
   731 E C1879937:Ethnic Group [Intellectual Product]
   726   C0682076:ethnic difference [Finding]
Processing 00000000.tx.178: However, most studies were strictly ethnically defined, so the population stratification effect is unlikely to have been of any considerable magnitude. 

Phrase: "However,"

Phrase: "most studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "strictly ethnically"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: ","

Phrase: "so"

Phrase: "the population stratification effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "have"

Phrase: "been of any considerable magnitude."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]
Processing 00000000.tx.179: Because of the increasing prevalence of Alzheimers disease worldwide, it is crucial to identify genetic risk factors for this neurodegenerative disease. 

Phrase: "Because of the increasing prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033105:Prevalence [Quantitative Concept]
   861   C0220900:prevalence [Quantitative Concept]

Phrase: "of Alzheimers disease worldwide,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "crucial to"

Phrase: "identify"

Phrase: "genetic risk factors for this neurodegenerative disease."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0814299:genetic risk factors [Qualitative Concept]
   800   C0850664:disease factors risk [Finding]
   778   C0035648:risk factors [Quantitative Concept]
   778   C1553898:risk factors [Idea or Concept]
   774   C0679238:disease factors [Functional Concept]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.180: Thus, the list of identified polymorphisms that may influence the risk of Alzheimers disease is continuously expanding (23, 29), but most of the reported associations of candidate genes to date remain nonreplicated or at least controversial after subsequent investigation. 

Phrase: "Thus,"

Phrase: "the list of identified polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0745732:List [Conceptual Entity]
   760   C3272378:LIST [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "influence"

Phrase: "the risk of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "is"

Phrase: "continuously"

Phrase: "expanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expanding [Spatial Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "29"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "most of the reported associations of candidate genes"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C1332838:Candidate Genes [Gene or Genome]
   744   C0004083:Associations [Mental Process]
   744   C0017337:Genes [Gene or Genome]
   744   C0205393:Most [Quantitative Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C3496591:Reported [Clinical Attribute]
   711 E C0439849:Association [Qualitative Concept]
   711 E C0596306:Association [Phenomenon or Process]
   711 E C0699792:association [Social Behavior]
   711 E C3273238:Report [Intellectual Product]

Phrase: "to date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "remain"

Phrase: "nonreplicated"

Phrase: "or at least controversial"

Phrase: "after subsequent investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.181: Early and small genetic association studies may come up with spurious findings (41, 51, 52). 

Phrase: "Early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "small genetic association studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   923   C2717878:Genetic Association Studies [Molecular Biology Research Technique]
   858   C2827447:Genetic Study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "come up"

Phrase: "with spurious findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "(41,"

Phrase: "51,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.182: Even when genetic associations are replicated, usually they do not have a major public health impact that would lead to screening recommendations (53). 

Phrase: "Even"

Phrase: "when"

Phrase: "genetic associations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "are"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: ","

Phrase: "usually"

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a major public health impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1825598:IMPACT [Gene or Genome]

Phrase: "that"

Phrase: "would"

Phrase: "lead to screening recommendations"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   819   C0524167:lead screening [Laboratory Procedure]
   819   C1327695:Lead screening [Laboratory Procedure]
   802   C0150600:Recommendation to [Health Care Activity]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0034866:recommendations [Idea or Concept]
   770   C0220908:Screening [Health Care Activity]
   770   C0220909:screening [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1698960:screening [Intellectual Product]
   770   C1710031:Screening [Diagnostic Procedure]
   770   C1710477:SCREENING [Research Activity]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737 E C1305399:screen [Functional Concept]
   737 E C1705053:Screen [Medical Device]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.183: Nevertheless, such knowledge could improve our understanding about the pathogenesis of complex diseases such as Alzheimers disease.  

Phrase: "Nevertheless,"

Phrase: "such knowledge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "could"

Phrase: "improve"

Phrase: "our understanding about the pathogenesis of complex diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162340:Understanding [Mental Process]

Phrase: "such as Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.184: LABORATORY TESTS TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  The methods used for CTSD genotyping in the analyzed studies are straightforward and include polymerase chain reaction (9) and dynamic allele-specific hybridization (14). 

Phrase: "LABORATORY TESTS TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   889   C0022885:laboratory testing [Laboratory Procedure]
   867   C0683443:test testing [Diagnostic Procedure]
           tests tests
   828   C0871511:methods testing [Intellectual Product]
   783   C0039593:Testing [Functional Concept]
   783   C0392366:testing [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "used for CTSD genotyping"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1332805:CATHEPSIN D [Gene or Genome]
   760   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1273517:used [Finding]
   760   C1285573:Genotyping [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "in the analyzed studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "straightforward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1272701:Straightforward [Qualitative Concept]

Phrase: "and"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "dynamic allele-specific hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020202:Hybridisation [Genetic Function]
   812   C1300517:Hybridization [Laboratory Procedure]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.185: The error rate due to misclassification is likely to be small. 

Phrase: "The error rate due to misclassification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0743559:error [Qualitative Concept]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
   753   C1608199:Error [Functional Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "small."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]
Processing 00000000.tx.186: Future studies should nevertheless ensure and clearly report that assessment of genotyping has been performed while blinded to the clinical status of the patient.  

Phrase: "Future studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "should"

Phrase: "nevertheless"

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "and"

Phrase: "clearly"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that assessment of genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "while"

Phrase: "blinded to the clinical status of the patient."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0449440:Clinical status [Qualitative Concept]
   767   C0449437:Patient status [Finding]
   744   C0030705:*^patient [Patient or Disabled Group]
   744   C0150108:Blinded [Research Activity]
   744   C0205210:Clinical [Qualitative Concept]
   744   C0449438:Status [Qualitative Concept]
   711 E C0456909:Blind [Disease or Syndrome]
   711 E C0525065:blind [Patient or Disabled Group]
Processing 00000000.tx.187: POPULATION TESTING TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  To date there has been no population testing of the CTSD polymorphism. 

Phrase: "POPULATION TESTING TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   749   C1514811:Reference [Idea or Concept]
   749   C1706462:Reference [Conceptual Entity]
   712   C0683443:testing testing [Diagnostic Procedure]

Phrase: "To date there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011008:Date [Temporal Concept]
   861   C2348077:Date [Food]

Phrase: "has"

Phrase: "been"

Phrase: "no population testing of the CTSD polymorphism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0039593:Testing [Functional Concept]
   744   C0392366:testing [Intellectual Product]
Processing 00000000.tx.188: Based on the results of the meta-analysis, such testing would not be indicated given the currently available data.  

Phrase: "Based on the results of the meta-analysis,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0282458:Meta-Analysis [Intellectual Product]
   770   C0920317:Meta-Analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1042496:Meta [Eukaryote]
   744   C1524024:analysis [Functional Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711 E C1880279:Base [Biomedical or Dental Material]
   711   C2825142:Result [Finding]

Phrase: "such"

Phrase: "testing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the currently available data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
Processing 00000000.tx.189: ACKNOWLEDGMENTS  The authors thank Jonathan A. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Jonathan A."
Processing 00000000.tx.190: Prince, Patrizia Mecocci, and Anthony J. 

Phrase: "Prince,"

Phrase: "Patrizia Mecocci,"

Phrase: "and"

Phrase: "Anthony J."
Processing 00000000.tx.191: Brookes for providing additional data from their studies.  

Phrase: "Brookes for providing additional data"

Phrase: "from their studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]
Processing 00000000.tx.192: NOTES  Correspondence to Dr. 

Phrase: "NOTES"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Correspondence to Dr."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.193: John P. 

Phrase: "John P."
Processing 00000000.tx.194: A. 

Phrase: "A."
Processing 00000000.tx.195: Ioannidis, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece (e-mail: jioannid{at}cc.uoi.gr ).  

Phrase: "Ioannidis,"

Phrase: "Department of Hygiene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Epidemiology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014507:Epidemiology [Biomedical Occupation or Discipline]
  1000   C0014508:epidemiology [Functional Concept]
  1000   C0699910:epidemiology [Health Care Activity]

Phrase: "University of Ioannina School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Ioannina 45110,"

Phrase: "Greece"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018226:Greece [Geographic Area]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "jioannid{at}cc.uoi.gr )."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1552950:[gr] [Quantitative Concept]
Processing 00000000.tx.196: REFERENCES TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING REFERENCES  McDermott JR, Gibson AM. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION GENE GENE VARIANTS DISEASE META-ANALYSIS METHODS META-ANALYSIS RESULTS DISCUSSION LABORATORY TESTS POPULATION TESTING"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   834   C0871511:methods testing [Intellectual Product]
   803   C0022885:laboratory testing [Laboratory Procedure]
   784   C0039593:Testing [Functional Concept]
   784   C0392366:testing [Intellectual Product]
   780   C0683443:test testing [Diagnostic Procedure]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "McDermott JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Gibson"

Phrase: "AM."
Processing 00000000.tx.197: Degradation of Alzheimers beta-amyloid protein by human cathepsin D. 

Phrase: "Degradation of Alzheimers beta-amyloid protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0597297:Protein Degradation [Molecular Function]
   783   C0597304:Protein Degradation [Molecular Function]
   783   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "by human cathepsin D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.198: Neuroreport 1996;7:21636.[ISI][Medline] Chevalier N, Vizzavona J, Marambaud P, et al. 

Phrase: "Neuroreport 1996"

Phrase: ";7"

Phrase: ":"

Phrase: "21636."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chevalier N,"

Phrase: "Vizzavona J,"

Phrase: "Marambaud P,"

Phrase: "et al."
Processing 00000000.tx.199: Cathepsin D displays in vitro beta-secretase-like specificity. 

Phrase: "Cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "in vitro beta-secretase-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1412727:SECRETASE, BETA [Gene or Genome]
   861   C1454853:beta-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "like specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.200: Brain Res 1997;750:1119.[CrossRef][ISI][Medline] Touitou I, Capony F, Brouillet JP, et al. 

Phrase: "Brain Res 1997"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ";750"

Phrase: ":"

Phrase: "1119."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Touitou I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Capony F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Brouillet JP,"

Phrase: "et al."
Processing 00000000.tx.201: Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reactionsingle strand conformational polymorphism analysis and possible consequences in cancer cells. 

Phrase: "Missense polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(C/T224"

Phrase: ")"

Phrase: "in the human cathepsin D pro-fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]
   804   C2987124:PRO [Intellectual Product]

Phrase: "determined by polymerase chain reactionsingle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0337112:Chain [Manufactured Object]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "conformational polymorphism analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0796451:polymorphism analysis [Diagnostic Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "possible consequences in cancer cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0686907:consequences [Functional Concept]
Processing 00000000.tx.202: Eur J Cancer 1994;30A:3904.[ISI][Medline] Papassotiropoulos A, Lewis HD, Bagli M, et al. 

Phrase: "Eur J Cancer 1994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: ";30A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553668:30a [Medical Device]

Phrase: ":"

Phrase: "3904."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Papassotiropoulos A,"

Phrase: "Lewis HD,"

Phrase: "Bagli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.203: Cerebrospinal fluid levels of -amyloid(42) in patients with Alzheimers disease are related to the exon 2 polymorphism of the cathepsin D gene. 

Phrase: "Cerebrospinal fluid levels of -amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(42"

Phrase: ")"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "related to the exon 2 polymorphism of the cathepsin D gene."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1332805:CATHEPSIN D [Gene or Genome]
   754   C0678951:gene polymorphism [Genetic Function]
   738   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0017337:Gene [Gene or Genome]
   738   C0032529:Polymorphism [Genetic Function]
   738   C0439849:Related [Qualitative Concept]
   738   C0445223:Related [Finding]
   738   C1882417:Polymorphism [Qualitative Concept]
   704 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.204: Neuroreport 2002;13:12914.[CrossRef][ISI][Medline] Payton A, Holland F, Diggle P, et al. 

Phrase: "Neuroreport 2002"

Phrase: ";13"

Phrase: ":"

Phrase: "12914."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Payton A,"

Phrase: "Holland F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Diggle P,"

Phrase: "et al."
Processing 00000000.tx.205: Cathepsin D exon 2 polymorphism associated with general intelligence in a healthy older population. 

Phrase: "Cathepsin D exon 2 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]

Phrase: "associated with general intelligence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0021704:Intelligence [Mental Process]
   770   C0205246:General [Spatial Concept]
   770   C1553889:General [Idea or Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a healthy older population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518563:Older Population [Population Group]
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.206: Mol Psychiatry 2003;8:1418.[CrossRef][ISI][Medline] Crawford FC, Freeman MJ, Schinka J, et al. 

Phrase: "Mol Psychiatry 2003"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0027960:Mole [Neoplastic Process]
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   755 E C0205487:Psychiatric [Functional Concept]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ";8"

Phrase: ":"

Phrase: "1418."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Crawford FC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2983605:FC [Activity]

Phrase: "Freeman MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Schinka J,"

Phrase: "et al."
Processing 00000000.tx.207: The genetic association between cathepsin D and Alzheimers disease. 

Phrase: "The genetic association between cathepsin D"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1328885:genetic association [Occupation or Discipline]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.208: Neurosci Lett 2000;289:615.[CrossRef][ISI][Medline] Papassotiropoulos A, Bagli M, Kurz A, et al. 

Phrase: "Neurosci Lett 2000"

Phrase: ";289"

Phrase: ":"

Phrase: "615."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Papassotiropoulos A,"

Phrase: "Bagli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kurz A,"

Phrase: "et al."
Processing 00000000.tx.209: A genetic variation of cathepsin D is a major risk factor for Alzheimers disease. 

Phrase: "A genetic variation of cathepsin D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0042333:Genetic Variation [Natural Phenomenon or Process]
   753   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "a major risk factor for Alzheimers disease."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.210: Ann Neurol 2000;47:399403.[CrossRef][ISI][Medline] Menzer G, Muller-Thomsen T, Meins W, et al. 

Phrase: "Ann Neurol 2000"

Phrase: ";47"

Phrase: ":"

Phrase: "399403."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Menzer G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Muller-Thomsen T,"

Phrase: "Meins W,"

Phrase: "et al."
Processing 00000000.tx.211: Non-replication of association between cathepsin D genotype and late onset Alzheimer disease. 

Phrase: "Non-replication of association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0598312:Replication [Genetic Function]
   770   C1518422:Non [Functional Concept]
   770   C1883725:replication [Qualitative Concept]

Phrase: "between cathepsin D genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017431:Genotype [Organism Attribute]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "and"

Phrase: "late onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.212: Am J Med Genet 2001;105:17982.[CrossRef][ISI][Medline] Papassotiropoulos A, Bagli M, Feder O, et al. 

Phrase: "Am"

Phrase: "J Med Genet 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";105"

Phrase: ":"

Phrase: "17982."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Papassotiropoulos A,"

Phrase: "Bagli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Feder O,"

Phrase: "et al."
Processing 00000000.tx.213: Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimers disease. 

Phrase: "Genetic polymorphism of cathepsin D"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   806   C0032529:Genetic Polymorphism [Genetic Function]
           Polymorphism
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0314603:Genetic [Functional Concept]
   760   C1882417:Polymorphism [Qualitative Concept]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "is"

Phrase: "strongly"

Phrase: "associated with the risk"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for developing sporadic Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.214: Neurosci Lett 1999;262:1714.[CrossRef][ISI][Medline] McIlroy SP, Dynan KB, McGleenon BM, et al. 

Phrase: "Neurosci Lett 1999"

Phrase: ";262"

Phrase: ":"

Phrase: "1714."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McIlroy SP,"

Phrase: "Dynan KB,"

Phrase: "McGleenon BM,"

Phrase: "et al."
Processing 00000000.tx.215: Cathepsin D gene exon 2 polymorphism and sporadic Alzheimers disease. 

Phrase: "Cathepsin D gene exon 2 polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0678951:gene polymorphism [Genetic Function]
   799   C0032529:Polymorphism [Genetic Function]
   799   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "sporadic Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.216: Neurosci Lett 1999;273:1401.[CrossRef][ISI][Medline] Mateo I, Sanchez-Guerra M, Combarros O, et al. 

Phrase: "Neurosci Lett 1999"

Phrase: ";273"

Phrase: ":"

Phrase: "1401."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mateo I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sanchez-Guerra M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Combarros O,"

Phrase: "et al."
Processing 00000000.tx.217: Lack of association between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish sample. 

Phrase: "Lack of association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332268:lack [Qualitative Concept]

Phrase: "between cathepsin D genetic polymorphism"
Meta Candidates (Total=19; Excluded=14; Pruned=0; Remaining=5)
   861   C0032529:Genetic Polymorphism [Genetic Function]
           Polymorphism
   812   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   812   C0314603:Genetic [Functional Concept]
   812   C1882417:Polymorphism [Qualitative Concept]
   756 E C0005615:Birth [Organism Function]
   756 E C0035150:Reproduction [Organism Function]
   756 E C0079946:origin [Classification]
   756 E C0439659:Origin [Temporal Concept]
   756 E C1550512:origin [Intellectual Product]
   756 E C1550722:birth [Idea or Concept]
   756 E C3245487:birth [Intellectual Product]
   729 E C0454729:Natal [Geographic Area]
   729 E C0559522:Genital [Body System]
   729 E C1546649:Genital [Intellectual Product]
   729 E C1550642:Genital [Body Substance]
   719 E C0205313:Original [Idea or Concept]
   719 E C2347409:Original [Occupational Activity]
   701 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "Alzheimer disease in a Spanish sample."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.218: Am J Med Genet 2002;114:313.[CrossRef][ISI][Medline] Ingegni T, Nocentini G, Mariani E, et al. 

Phrase: "Am"

Phrase: "J Med Genet 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";114"

Phrase: ":"

Phrase: "313."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ingegni T,"

Phrase: "Nocentini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Mariani E,"

Phrase: "et al."
Processing 00000000.tx.219: Cathepsin D polymorphism in Italian elderly subjects with sporadic late-onset Alzheimers disease. 

Phrase: "Cathepsin D polymorphism in Italian elderly subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with sporadic late-onset Alzheimers disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   937   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   840   C0002395:Alzheimers disease [Disease or Syndrome]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.220: Dement Geriatr Cogn Disord 2003;16:1515.[CrossRef][ISI][Medline] Bhojak TJ, DeKosky ST, Ganguli M, et al. 

Phrase: "Dement Geriatr Cogn Disord 2003"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0860630:dement [Mental or Behavioral Dysfunction]
   704 E C0011265:dementia [Mental or Behavioral Dysfunction]
   704 E C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ";16"

Phrase: ":"

Phrase: "1515."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bhojak TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "DeKosky ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Ganguli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.221: Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimers disease. 

Phrase: "Genetic polymorphisms in the cathespin D"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0032529:Genetic Polymorphisms [Genetic Function]
           polymorphisms
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "interleukin-6 genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C1704829:Interleukin-6 Gene [Gene or Genome]
   896   C1334205:Interleukin Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
   734   C0021760:Interleukin-6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1527132:interleukin 6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "the risk of Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.222: Neurosci Lett 2000;288:214.[CrossRef][ISI][Medline] Prince JA, Feuk L, Sawyer SL, et al. 

Phrase: "Neurosci Lett 2000"

Phrase: ";288"

Phrase: ":"

Phrase: "214."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Prince JA,"

Phrase: "Feuk L,"

Phrase: "Sawyer SL,"

Phrase: "et al."
Processing 00000000.tx.223: Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimers disease. 

Phrase: "Lack of replication of association findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "in complex disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "an analysis of 15 polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0796451:polymorphism analysis [Diagnostic Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in prior candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1332838:Candidate Genes [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "for sporadic Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.224: Eur J Hum Genet 2001;9:43744.[CrossRef][ISI][Medline] Matsui T, Morikawa Y, Tojo M, et al. 

Phrase: "Eur J Hum Genet 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0325074:Genet [Mammal]

Phrase: ";9"

Phrase: ":"

Phrase: "43744."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matsui T,"

Phrase: "Morikawa Y,"

Phrase: "Tojo M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.225: Cathepsin D polymorphism not associated with Alzheimers disease in Japanese. 

Phrase: "Cathepsin D polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with Alzheimers disease"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in Japanese."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556094:Japanese [Population Group]
Processing 00000000.tx.226: Ann Neurol 2001;49:5445. 

Phrase: "Ann Neurol 2001"

Phrase: ";49"

Phrase: ":"

Phrase: "5445."
Processing 00000000.tx.227: Bagnoli S, Nacmias B, Tedde A, et al. 

Phrase: "Bagnoli S,"

Phrase: "Nacmias B,"

Phrase: "Tedde A,"

Phrase: "et al."
Processing 00000000.tx.228: Cathepsin D polymorphism in Italian sporadic and familial Alzheimers disease. 

Phrase: "Cathepsin D polymorphism in Italian sporadic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "familial Alzheimers disease."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.229: Neurosci Lett 2002;328:2736.[CrossRef][ISI][Medline] Bertram L, Guenette S, Jones J, et al. 

Phrase: "Neurosci Lett 2002"

Phrase: ";328"

Phrase: ":"

Phrase: "2736."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bertram L,"

Phrase: "Guenette S,"

Phrase: "Jones J,"

Phrase: "et al."
Processing 00000000.tx.230: No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease. 

Phrase: "No evidence for genetic association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "or"

Phrase: "linkage of the cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023745:linkage [Molecular Function]

Phrase: "(CTSD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "exon 2 polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.231: Ann Neurol 2001;49:11416.[CrossRef][ISI][Medline] Emahazion T, Feuk L, Jobs M, et al. 

Phrase: "Ann Neurol 2001"

Phrase: ";49"

Phrase: ":"

Phrase: "11416."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Emahazion T,"

Phrase: "Feuk L,"

Phrase: "Jobs M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.232: SNP association studies in Alzheimers disease highlight problems for complex disease analysis. 

Phrase: "SNP association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "studies in Alzheimers disease highlight problems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0557651:Study [Manufactured Object]
   753   C0947630:studies [Laboratory Procedure]
   753   C1546466:Problems [Idea or Concept]
   753   C2603343:Study [Research Activity]
   719 E C0033213:Problem [Finding]

Phrase: "for complex disease analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.233: Trends Genet 2001;17:40713.[CrossRef][ISI][Medline] Styczynska M, Religa D, Pfeffer A, et al. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: ";17"

Phrase: ":"

Phrase: "40713."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Styczynska M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Religa D,"

Phrase: "Pfeffer A,"

Phrase: "et al."
Processing 00000000.tx.234: Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimers disease. 

Phrase: "Simultaneous analysis of five genetic risk factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0085801:analysis factors [Quantitative Concept]
   774   C0679560:genetic analysis [Laboratory Procedure]
   774   C0796344:Genetic Analysis [Laboratory Procedure]
   774   C0814767:risk analysis [Qualitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in Polish patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.235: Neurosci Lett 2003;344:99102.[CrossRef][ISI][Medline] Farrer LA, Cupples LA, Haines JL, et al. 

Phrase: "Neurosci Lett 2003"

Phrase: ";344"

Phrase: ":"

Phrase: "99102."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrer LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Cupples LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Haines JL,"

Phrase: "et al."
Processing 00000000.tx.236: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. 

Phrase: "Effects of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity on the association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015031:Ethnicity [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]

Phrase: "between apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.237: A meta-analysis. 

Phrase: "A meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.238: APOE and Alzheimer Disease Meta Analysis Consortium. 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer Disease Meta Analysis Consortium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1513822:Consortium [Professional or Occupational Group]
   804   C1880171:Consortium [Professional or Occupational Group]
Processing 00000000.tx.239: JAMA 1997;278:134956.[Abstract] Hebert LE, Scherr PA, Beckett LA, et al. 

Phrase: "JAMA 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";278"

Phrase: ":"

Phrase: "134956."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hebert LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Scherr PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Beckett LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "et al."
Processing 00000000.tx.240: Age-specific incidence of Alzheimers disease in a community population. 

Phrase: "Age-specific incidence of Alzheimers disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]

Phrase: "in a community population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.241: JAMA 1995;273:13549.[Abstract] Cummings JL, Cole G. 

Phrase: "JAMA 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";273"

Phrase: ":"

Phrase: "13549."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cummings JL,"

Phrase: "Cole G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.242: Alzheimer disease. 

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.243: JAMA 2002;287:23358.[Free FullText] St George-Hyslop PH. 

Phrase: "JAMA 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";287"

Phrase: ":"

Phrase: "23358."

Phrase: "[Free FullText"

Phrase: "] St George-Hyslop PH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
Processing 00000000.tx.244: Molecular genetics of Alzheimers disease. 

Phrase: "Molecular genetics of Alzheimers disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   797   C0019247:Molecular Disease [Disease or Syndrome]
           genetics disease
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
   760   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.245: Biol Psychiatry 2000;47:18399.[CrossRef][ISI][Medline] Gao S, Hendrie HC, Hall KS, et al. 

Phrase: "Biol Psychiatry 2000"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0033872:Psychiatry [Professional or Occupational Group]
   827   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   755 E C0205487:Psychiatric [Functional Concept]

Phrase: ";47"

Phrase: ":"

Phrase: "18399."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gao S,"

Phrase: "Hendrie HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Hall KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.246: The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. 

Phrase: "The relationships between age,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0439849:Relationships [Qualitative Concept]
   737 E C1705630:Relationship [Idea or Concept]
   737 E C1706279:Relationship [Idea or Concept]
   737 E C3540605:Relationship [Intellectual Product]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "the incidence of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.247: Arch Gen Psychiatry 1998;55:80915.[Abstract/Free FullText] Fleminger S, Oliver DL, Lovestone S, et al. 

Phrase: "Arch Gen Psychiatry 1998"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0033872:Psychiatry [Professional or Occupational Group]
   812   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   812   C0230467:arch [Body Location or Region]
   812   C0741204:ARCH [Body Space or Junction]
   812   C1704351:GEN [Quantitative Concept]
   812   C2239486:Gen [Gene or Genome]
   741 E C0205487:Psychiatric [Functional Concept]

Phrase: ";55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "80915."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fleminger S,"

Phrase: "Oliver DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Lovestone S,"

Phrase: "et al."
Processing 00000000.tx.248: Head injury as a risk factor for Alzheimers disease: the evidence 10 years on; 

Phrase: "Head injury as a risk factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0018674:Head injury [Injury or Poisoning]
   783   C0582456:Injury risk [Finding]
   753   C0018670:Head [Body Location or Region]
   753   C1281590:Head [Body Part, Organ, or Organ Component]
   753   C1706305:Head [Manufactured Object]
   753   C3263722:Injury [Injury or Poisoning]
   753   C3263723:Injury [Injury or Poisoning]

Phrase: "for Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "the evidence 10 years on"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439234:years [Temporal Concept]
   726 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.249: a partial replication. 

Phrase: "a partial replication."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0598312:Replication [Genetic Function]
   861   C1883725:replication [Qualitative Concept]
   789 E C0205173:Replicate [Functional Concept]
   789 E C0205341:Replicate [Functional Concept]
Processing 00000000.tx.250: J Neurol Neurosurg Psychiatry 2003;74:85762.[Abstract/Free FullText] Launer LJ, Andersen K, Dewey ME, et al. 

Phrase: "J Neurol Neurosurg Psychiatry 2003"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0033872:Psychiatry [Professional or Occupational Group]
   804   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   733 E C0205487:Psychiatric [Functional Concept]

Phrase: ";74"

Phrase: ":"

Phrase: "85762."

Phrase: "[Abstract/Free FullText"

Phrase: "] Launer LJ,"

Phrase: "Andersen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Dewey"

Phrase: "ME,"

Phrase: "et al."
Processing 00000000.tx.251: Rates and risk factors for dementia and Alzheimers disease. 

Phrase: "Rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "risk factors for dementia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0035648:risk factors [Quantitative Concept]
   833   C1553898:risk factors [Idea or Concept]
   770   C0035647:Risk [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.252: Neurology 1999;52:7884.[Abstract/Free FullText] McDowell I. 

Phrase: "Neurology 1999"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";52"

Phrase: ":"

Phrase: "7884."

Phrase: "[Abstract/Free FullText"

Phrase: "] McDowell I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.253: Alzheimers disease: insights from epidemiology. 

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "insights from epidemiology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0233820:insights [Mental Process]
Processing 00000000.tx.254: Aging (Milano) 2001;13:14362.[ISI][Medline] Hendrie HC, Ogunniyi A, Hall KS, et al. 

Phrase: "Aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "(Milano"

Phrase: ")"

Phrase: "2001"

Phrase: ";13"

Phrase: ":"

Phrase: "14362."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hendrie HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Ogunniyi A,"

Phrase: "Hall KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.255: Incidence of dementia and Alzheimers disease in 2 communities. 

Phrase: "Incidence of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021149:Incidence [Quantitative Concept]
   790   C0220856:incidence [Functional Concept]
   718 E C1551358:incident [Idea or Concept]

Phrase: "and"

Phrase: "Alzheimers disease in 2 communities."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C1425076:MALS-2 [Gene or Genome]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.256: JAMA 2001;285:73947.[Abstract/Free FullText] Combarros O, Alvarez-Arcaya A, Sanchez-Guerra M, et al. 

Phrase: "JAMA 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ";285"

Phrase: ":"

Phrase: "73947."

Phrase: "[Abstract/Free FullText"

Phrase: "] Combarros O,"

Phrase: "Alvarez-Arcaya A,"

Phrase: "Sanchez-Guerra M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.257: Candidate gene association studies in sporadic Alzheimers disease. 

Phrase: "Candidate gene association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   734   C1332838:Candidate Gene [Gene or Genome]

Phrase: "studies in sporadic Alzheimers disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0002395:Alzheimers disease [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205422:Sporadic [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C2603343:Study [Research Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.258: Dement Geriatr Cogn Disord 2002;14:4154.[CrossRef][ISI][Medline] Combarros O, Infante J, Llorca J, et al. 

Phrase: "Dement Geriatr Cogn Disord 2002"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0860630:dement [Mental or Behavioral Dysfunction]
   704 E C0011265:dementia [Mental or Behavioral Dysfunction]
   704 E C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ";14"

Phrase: ":"

Phrase: "4154."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Combarros O,"

Phrase: "Infante J,"

Phrase: "Llorca J,"

Phrase: "et al."
Processing 00000000.tx.259: The myeloperoxidase gene in Alzheimers disease: a case-control study and meta-analysis. 

Phrase: "The myeloperoxidase gene in Alzheimers disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1417245:Myeloperoxidase Gene [Gene or Genome]
   756   C1416989:MAL gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "a case-control study"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0007328:Case-Control Study [Research Activity]
   913   C0085973:Case Study [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2603343:Study [Research Activity]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.260: Neurosci Lett 2002;326:336.[CrossRef][ISI][Medline] Dermaut B, Roks G, Theuns J, et al. 

Phrase: "Neurosci Lett 2002"

Phrase: ";326"

Phrase: ":"

Phrase: "336."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dermaut B,"

Phrase: "Roks G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Theuns J,"

Phrase: "et al."
Processing 00000000.tx.261: Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimers disease. 

Phrase: "Variable expression of presenilin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1868500:Variable expression [Finding]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a major determinant of risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521761:Determinant [Functional Concept]

Phrase: "for late-onset Alzheimers disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.262: J Neurol 2001;248:9359.[CrossRef][ISI][Medline] Koster MN, Dermaut B, Cruts M, et al. 

Phrase: "J Neurol 2001"

Phrase: ";248"

Phrase: ":"

Phrase: "9359."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koster MN,"

Phrase: "Dermaut B,"

Phrase: "Cruts M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.263: The 2-macroglobulin gene in AD: a population-based study and meta-analysis. 

Phrase: "The 2-macroglobulin gene in AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017337:Gene [Gene or Genome]
   746   C1416989:MAL gene [Gene or Genome]

Phrase: ":"

Phrase: "a population-based study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709599:Population Based Study [Research Activity]
   913   C0681876:Population Study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.264: Neurology 2000;55:67884.[Abstract/Free FullText] Russ C, Powell JF, Zhao J, et al. 

Phrase: "Neurology 2000"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ";55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "67884."

Phrase: "[Abstract/Free FullText"

Phrase: "] Russ C,"

Phrase: "Powell JF,"

Phrase: "Zhao J,"

Phrase: "et al."
Processing 00000000.tx.265: The microtubule associated protein tau gene and Alzheimers diseasean association study and meta-analysis. 

Phrase: "The microtubule associated protein tau gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1446659:Microtubule-Associated Protein Tau Gene [Gene or Genome]
           MICROTUBULE-ASSOCIATED PROTEIN TAU
   853   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   771   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   722   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimers diseasean association study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.266: Neurosci Lett 2001;314:926.[CrossRef][ISI][Medline] Sanchez-Guerra M, Combarros O, Infante J, et al. 

Phrase: "Neurosci Lett 2001"

Phrase: ";314"

Phrase: ":"

Phrase: "926."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sanchez-Guerra M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Combarros O,"

Phrase: "Infante J,"

Phrase: "et al."
Processing 00000000.tx.267: Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimers disease. 

Phrase: "Case-control study"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0007328:Case-Control Study [Research Activity]
   913   C0085973:Case Study [Intellectual Product]
   901   C0872128:case control [Health Care Activity]
   827   C0243148:control [Qualitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0868928:Case [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2603343:Study [Research Activity]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "of low density lipoprotein receptor-related protein gene exon 3 polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   824   C0678951:gene polymorphism [Genetic Function]
   790   C0032529:Polymorphism [Genetic Function]
   790   C1882417:Polymorphism [Qualitative Concept]
   752   C1416915:LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 3 [Gene or Genome]
   707   C1366529:Low density lipoprotein receptor gene [Gene or Genome]

Phrase: "in Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.268: Neurosci Lett 2001;316:1720.[CrossRef][ISI][Medline] Kehoe PG, Katzov H, Feuk L, et al. 

Phrase: "Neurosci Lett 2001"

Phrase: ";316"

Phrase: ":"

Phrase: "1720."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kehoe PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Katzov H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Feuk L,"

Phrase: "et al."
Processing 00000000.tx.269: Haplotypes extending across ACE are associated with Alzheimers disease. 

Phrase: "Haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "extending across ACE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0439792:Extending [Spatial Concept]
   756 E C0231448:Extend [Functional Concept]

Phrase: "are"

Phrase: "associated with Alzheimers disease."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.270: Hum Mol Genet 2003;12:85967.[Abstract/Free FullText] Lau J, Ioannidis JP, Schmid CH. 

Phrase: "Hum Mol Genet 2003"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";12"

Phrase: ":"

Phrase: "85967."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lau J,"

Phrase: "Ioannidis JP,"

Phrase: "Schmid CH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]
Processing 00000000.tx.271: Quantitative synthesis in systematic reviews. 

Phrase: "Quantitative synthesis in systematic reviews."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
Processing 00000000.tx.272: Ann Intern Med 1997;127:8206.[Abstract/Free FullText] Petitti DB. 

Phrase: "Ann Intern Med 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1144859:INTERN [Professional or Occupational Group]

Phrase: ";127"

Phrase: ":"

Phrase: "8206."

Phrase: "[Abstract/Free FullText"

Phrase: "] Petitti DB."
Processing 00000000.tx.273: Meta-analysis, decision analysis and cost-effectiveness analysis. 

Phrase: "Meta-analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]

Phrase: "decision analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011108:Decision Analysis [Occupation or Discipline]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0679006:Decision [Mental Process]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "cost-effectiveness analysis."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1511536:Cost Effectiveness Analysis [Occupational Activity]
   913   C0010171:Cost Analysis [Occupational Activity]
   901   C0010181:Cost Effectiveness [Quantitative Concept]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0010186:Cost [Quantitative Concept]
   827   C0220812:cost [Quantitative Concept]
   827   C0936012:Analysis [Research Activity]
   827   C1280519:Effectiveness [Qualitative Concept]
   827   C1524024:analysis [Functional Concept]
   755 E C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.274: New York, NY: Oxford University Press, 1994. 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ":"

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "1994."
Processing 00000000.tx.275: Lau J, Antman EM, Jimenez-Silva J, et al. 

Phrase: "Lau J,"

Phrase: "Antman EM,"

Phrase: "Jimenez-Silva J,"

Phrase: "et al."
Processing 00000000.tx.276: Cumulative meta-analysis of therapeutic trials for myocardial infarction. 

Phrase: "Cumulative meta-analysis of therapeutic trials"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "for myocardial infarction."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0027051:Myocardial Infarction [Disease or Syndrome]
  1000   C0428953:MYOCARDIAL INFARCTION [Finding]
  1000   C2926063:Myocardial infarction [Clinical Attribute]
   861   C0021308:Infarction [Pathologic Function]
   861   C0027061:Myocardial [Tissue]
   861   C1522564:Myocardial [Spatial Concept]
   789 E C0333541:Infarcted [Functional Concept]
Processing 00000000.tx.277: N Engl J Med 1992;327:24854.[Abstract] Ioannidis JP, Contopoulos-Ioannidis DG, Lau J. 

Phrase: "N Engl J Med 1992"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ";327"

Phrase: ":"

Phrase: "24854."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ioannidis JP,"

Phrase: "Contopoulos-Ioannidis DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1275573:dg [Quantitative Concept]

Phrase: "Lau J."
Processing 00000000.tx.278: Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. 

Phrase: "Recursive cumulative meta-analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0282458:Meta-Analysis [Intellectual Product]
   861   C0920317:Meta-Analysis [Research Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1042496:Meta [Eukaryote]
   812   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "a diagnostic for the evolution of total randomized evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0011900:Diagnostic [Finding]
   742   C0348026:Diagnostic [Functional Concept]

Phrase: "from group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "individual patient data."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C2707520:Patient data [Intellectual Product]
   827   C0027361:Individual [Population Group]
   827   C0030705:*^patient [Patient or Disabled Group]
   827   C0237401:Individual [Human]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
Processing 00000000.tx.279: J Clin Epidemiol 1999;52:28191.[CrossRef][ISI][Medline] Ioannidis J, Lau J. 

Phrase: "J Clin Epidemiol 1999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ";52"

Phrase: ":"

Phrase: "28191."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ioannidis J,"

Phrase: "Lau J."
Processing 00000000.tx.280: Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. 

Phrase: "Evolution of treatment effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015219:Evolution [Genetic Function]

Phrase: "over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: ":"

Phrase: "empirical insight from recursive cumulative metaanalyses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:Insight [Mental Process]
Processing 00000000.tx.281: Proc Natl Acad Sci U S A 2001;98:8316.[Abstract/Free FullText] Ioannidis JP, Ntzani EE, Trikalinos TA, et al. 

Phrase: "Proc Natl Acad Sci U S A 2001"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ";98"

Phrase: ":"

Phrase: "8316."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ioannidis JP,"

Phrase: "Ntzani EE,"

Phrase: "Trikalinos TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.282: Replication validity of genetic association studies. 

Phrase: "Replication validity of genetic association studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2349101:Validity [Quantitative Concept]
Processing 00000000.tx.283: Nat Genet 2001;29:3069.[CrossRef][ISI][Medline] Begg CB, Mazumdar M. 

Phrase: "Nat Genet 2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ";29"

Phrase: ":"

Phrase: "3069."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Begg CB,"

Phrase: "Mazumdar M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.284: Operating characteristics of a rank correlation test for publication bias. 

Phrase: "Operating characteristics of a rank correlation test"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "for publication bias."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0206086:Publication Bias [Qualitative Concept]
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]
Processing 00000000.tx.285: Biometrics 1994;50:1088101.[ISI][Medline] Ioannidis JP, Trikalinos TA, Ntzani EE, et al. 

Phrase: "Biometrics 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2718322:Biometrics [Occupation or Discipline]

Phrase: ";50"

Phrase: ":"

Phrase: "1088101."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ioannidis JP,"

Phrase: "Trikalinos TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Ntzani EE,"

Phrase: "et al."
Processing 00000000.tx.286: Genetic associations in large versus small studies: an empirical assessment. 

Phrase: "Genetic associations in large"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   816   C1328885:genetic association [Occupation or Discipline]
   770   C0004083:Associations [Mental Process]
   737 E C0439849:Association [Qualitative Concept]
   737 E C0596306:Association [Phenomenon or Process]
   737 E C0699792:association [Social Behavior]

Phrase: "versus"

Phrase: "small studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "an empirical assessment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261322:Assessment [Health Care Activity]
   861   C1516048:Assessment [Activity]
Processing 00000000.tx.287: Lancet 2003;361:56771.[CrossRef][ISI][Medline] Kenessey A, Nacharaju P, Ko LW, et al. 

Phrase: "Lancet 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";361"

Phrase: ":"

Phrase: "56771."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kenessey A,"

Phrase: "Nacharaju P,"

Phrase: "Ko LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "et al."
Processing 00000000.tx.288: Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. 

Phrase: "Degradation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "by lysosomal enzyme cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332805:CATHEPSIN D [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "implication for Alzheimer neurofibrillary degeneration."
Processing 00000000.tx.289: J Neurochem 1997;69:202638.[ISI][Medline] Kehoe P, Wavrant-De Vrieze F, Crook R, et al. 

Phrase: "J Neurochem 1997"

Phrase: ";69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "202638."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kehoe P,"

Phrase: "Wavrant-De Vrieze F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "Crook R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.290: A full genome scan for late onset Alzheimers disease. 

Phrase: "A full genome scan for late onset Alzheimers disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1517519:Genome Scan [Molecular Biology Research Technique]
   742   C0017428:Genome [Gene or Genome]
   742   C0034606:Scan [Diagnostic Procedure]
   742   C0441633:Scan [Diagnostic Procedure]
   742   C2338314:Genome [Conceptual Entity]
   742   C2826292:SCAN [Finding]
Processing 00000000.tx.291: Hum Mol Genet 1999;8:23745.[Abstract/Free FullText] Collins JS, Perry RT, Watson B Jr, et al. 

Phrase: "Hum Mol Genet 1999"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";8"

Phrase: ":"

Phrase: "23745."

Phrase: "[Abstract/Free FullText"

Phrase: "] Collins JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Perry RT,"

Phrase: "Watson B Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "et al."
Processing 00000000.tx.292: Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimers disease: the NIMH Alzheimer Disease Genetics Initiative. 

Phrase: "Association of a haplotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "for tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "in siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037047:Siblings [Family Group]
   966 E C1611273:Sibling [Intellectual Product]

Phrase: "with late-onset Alzheimers disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "the NIMH Alzheimer Disease Genetics Initiative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0424093:Initiative [Mental Process]
Processing 00000000.tx.293: Am J Med Genet 2000;96:82330.[CrossRef][ISI][Medline] Farrer LA, Bowirrat A, Friedland RP, et al. 

Phrase: "Am"

Phrase: "J Med Genet 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0325074:Genet [Mammal]

Phrase: ";96"

Phrase: ":"

Phrase: "82330."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrer LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Bowirrat A,"

Phrase: "Friedland RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "et al."
Processing 00000000.tx.294: Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. 

Phrase: "Identification of multiple loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "for Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in a consanguineous Israeli-Arab community."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0009462:Community [Geographic Area]
Processing 00000000.tx.295: Hum Mol Genet 2003;12:41522.[Abstract/Free FullText] Lehmann DJ, Williams J, McBroom J, et al. 

Phrase: "Hum Mol Genet 2003"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ";12"

Phrase: ":"

Phrase: "41522."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lehmann DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Williams J,"

Phrase: "McBroom J,"

Phrase: "et al."
Processing 00000000.tx.296: Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimers disease and to identify high-risk subgroups. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "meta-analysis to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0282458:Meta-Analysis [Intellectual Product]
   901   C0920317:Meta-Analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1042496:Meta [Eukaryote]
   827   C1524024:analysis [Functional Concept]

Phrase: "explain"

Phrase: "the diversity of results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880371:Diversity [Qualitative Concept]

Phrase: "in genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "of late-onset Alzheimers disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimers disease [Disease or Syndrome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "high-risk subgroups."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1079230:subgroups [Virus]
   793 E C1515021:Subgroup [Classification]
   734   C0332167:High Risk [Qualitative Concept]
   734   C3272283:High Risk [Finding]
Processing 00000000.tx.297: Neuroscience 2001;108:54154.[CrossRef][ISI][Medline] Oxman AD, Guyatt GH. 

Phrase: "Neuroscience 2001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ";108"

Phrase: ":"

Phrase: "54154."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Oxman AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "Guyatt GH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]
Processing 00000000.tx.298: A consumers guide to subgroup analyses. 

Phrase: "A consumers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707496:Consumer [Population Group]
   966   C3273186:consumer [Intellectual Product]

Phrase: "guide to subgroup analyses."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0181090:Guide [Professional or Occupational Group]
   770   C0302614:Guide [Medical Device]
   770   C1079230:subgroup [Virus]
   770   C1515021:Subgroup [Classification]
   770   C1706050:Guide [Manufactured Object]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
Processing 00000000.tx.299: Ann Intern Med 1992;116:7884.[ISI][Medline] Cardon LR, Palmer LJ. 

Phrase: "Ann Intern Med 1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1144859:INTERN [Professional or Occupational Group]

Phrase: ";116"

Phrase: ":"

Phrase: "7884."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cardon LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Palmer LJ."
Processing 00000000.tx.300: Population stratification and spurious allelic association. 

Phrase: "Population stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514983:Stratification [Research Activity]

Phrase: "and"

Phrase: "spurious allelic association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.301: Lancet 2003;361:598604.[CrossRef][ISI][Medline] Lohmueller KE, Pearce CL, Pike M, et al. 

Phrase: "Lancet 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ";361"

Phrase: ":"

Phrase: "598604."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lohmueller KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Pearce CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Pike M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.302: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. 

Phrase: "Meta-analysis of genetic association studies"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0282458:Meta-Analysis [Intellectual Product]
   790   C0920317:Meta-Analysis [Research Activity]
   783   C0679560:genetic analysis [Laboratory Procedure]
   783   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1042496:Meta [Eukaryote]
   753   C1524024:analysis [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a contribution of common variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to common disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.303: Nat Genet 2003;33:17782.[CrossRef][ISI][Medline] Ioannidis JPA. 

Phrase: "Nat Genet 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0325074:Genet [Mammal]

Phrase: ";33"

Phrase: ":"

Phrase: "17782."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ioannidis JPA."
Processing 00000000.tx.304: Genetic associations: false or true? 

Phrase: "Genetic associations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: ":"

Phrase: "false"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205237:False [Qualitative Concept]

Phrase: "or"

Phrase: "true?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205238:True [Qualitative Concept]
Processing 00000000.tx.305: Trends Mol Med 2003;9:1358.[CrossRef][ISI][Medline] Little J, Khoury MJ, Bradley L, et al. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Mol Med 2003"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ";9"

Phrase: ":"

Phrase: "1358."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Little J,"

Phrase: "Khoury MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Bradley L,"

Phrase: "et al."
Processing 00000000.tx.306: The Human Genome Project is complete. 

Phrase: "The Human Genome Project"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0020125:Human Genome Project [Research Activity]
   901   C0017429:Genome, Human [Gene or Genome]
   827   C0017428:Genome [Gene or Genome]
   827   C0086418:Human [Human]
   827   C1709701:Project [Conceptual Entity]
   827   C2338314:Genome [Conceptual Entity]

Phrase: "is"

Phrase: "complete."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205197:Complete [Qualitative Concept]
  1000   C0725685:COMPLEAT [Food]
   928 E C0439812:Completeness [Qualitative Concept]
Processing 00000000.tx.307: How do we develop a handle for the pump? 

Phrase: "How"

Phrase: "do"

Phrase: "we"

Phrase: "develop"

Phrase: "a handle for the pump?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1562931:Pump Handle [Finding]
   760   C1708320:Handle [Conceptual Entity]
Processing 00000000.tx.308: Am J Epidemiol 2003;157:66773.[Free FullText]

Phrase: "Am"

Phrase: "J Epidemiol 2003"

Phrase: ";157"

Phrase: ":"

Phrase: "66773."

Phrase: "[Free FullText"

Phrase: "]"

